<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2024-10-02" version="270" xmlns="http://uniprot.org/uniprot">
  <accession>P09874</accession>
  <accession>B1ANJ4</accession>
  <accession>Q8IUZ9</accession>
  <name>PARP1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="111 113">Poly [ADP-ribose] polymerase 1</fullName>
      <shortName evidence="108">PARP-1</shortName>
      <ecNumber evidence="24 28 49 51 59 81 102">2.4.2.30</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName evidence="112">ADP-ribosyltransferase diphtheria toxin-like 1</fullName>
      <shortName evidence="112">ARTD1</shortName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="118">DNA ADP-ribosyltransferase PARP1</fullName>
      <ecNumber evidence="57">2.4.2.-</ecNumber>
    </alternativeName>
    <alternativeName>
      <fullName evidence="117">NAD(+) ADP-ribosyltransferase 1</fullName>
      <shortName evidence="117">ADPRT 1</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>Poly[ADP-ribose] synthase 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="118">Protein poly-ADP-ribosyltransferase PARP1</fullName>
      <ecNumber evidence="28 49 55 81 84 86 98">2.4.2.-</ecNumber>
    </alternativeName>
    <component>
      <recommendedName>
        <fullName evidence="118">Poly [ADP-ribose] polymerase 1, processed C-terminus</fullName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="114">Poly [ADP-ribose] polymerase 1, 89-kDa form</fullName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="118">Poly [ADP-ribose] polymerase 1, processed N-terminus</fullName>
        <shortName evidence="115">NT-PARP-1</shortName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="114">Poly [ADP-ribose] polymerase 1, 24-kDa form</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="116">Poly [ADP-ribose] polymerase 1, 28-kDa form</fullName>
      </alternativeName>
    </component>
  </protein>
  <gene>
    <name evidence="110 125" type="primary">PARP1</name>
    <name evidence="117" type="synonym">ADPRT</name>
    <name type="synonym">PPOL</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1987" name="Biochem. Biophys. Res. Commun." volume="148" first="617" last="622">
      <title>Nucleotide sequence of a full-length cDNA for human fibroblast poly(ADP-ribose) polymerase.</title>
      <authorList>
        <person name="Uchida K."/>
        <person name="Morita T."/>
        <person name="Sato T."/>
        <person name="Ogura T."/>
        <person name="Yamashita R."/>
        <person name="Noguchi S."/>
        <person name="Suzuki H."/>
        <person name="Nyunoya H."/>
        <person name="Miwa M."/>
        <person name="Sugimura T."/>
      </authorList>
      <dbReference type="PubMed" id="3120710"/>
      <dbReference type="DOI" id="10.1016/0006-291x(87)90921-1"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <source>
      <tissue>Fibroblast</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="15990" last="15997">
      <title>Primary structure of human poly(ADP-ribose) synthetase as deduced from cDNA sequence.</title>
      <authorList>
        <person name="Kurosaki T."/>
        <person name="Ushiro H."/>
        <person name="Mitsuuchi Y."/>
        <person name="Suzuki S."/>
        <person name="Matsuda M."/>
        <person name="Matsuda Y."/>
        <person name="Katunuma N."/>
        <person name="Kangawa K."/>
        <person name="Matsuo H."/>
        <person name="Hirose T."/>
        <person name="Inayama S."/>
        <person name="Shizuta Y."/>
      </authorList>
      <dbReference type="PubMed" id="2824474"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(18)47687-9"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <source>
      <tissue>Fibroblast</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="8370" last="8374">
      <title>cDNA sequence, protein structure, and chromosomal location of the human gene for poly(ADP-ribose) polymerase.</title>
      <authorList>
        <person name="Cherney B.W."/>
        <person name="McBride O.W."/>
        <person name="Chen D."/>
        <person name="Alkhatib H."/>
        <person name="Bhatia K."/>
        <person name="Hensley P."/>
        <person name="Smulson M.E."/>
      </authorList>
      <dbReference type="PubMed" id="2891139"/>
      <dbReference type="DOI" id="10.1073/pnas.84.23.8370"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <scope>VARIANT ARG-940</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="1989" name="DNA" volume="8" first="575" last="580">
      <title>Human nuclear NAD+ ADP-ribosyltransferase(polymerizing): organization of the gene.</title>
      <authorList>
        <person name="Auer B."/>
        <person name="Nagl U."/>
        <person name="Herzog H."/>
        <person name="Schneider R."/>
        <person name="Schweiger M."/>
      </authorList>
      <dbReference type="PubMed" id="2513174"/>
      <dbReference type="DOI" id="10.1089/dna.1989.8.575"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="submission" date="2002-06" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <consortium name="NIEHS SNPs program"/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>VARIANTS THR-188; ILE-334; TYR-383; ALA-762 AND ARG-940</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
      <title>The DNA sequence and biological annotation of human chromosome 1.</title>
      <authorList>
        <person name="Gregory S.G."/>
        <person name="Barlow K.F."/>
        <person name="McLay K.E."/>
        <person name="Kaul R."/>
        <person name="Swarbreck D."/>
        <person name="Dunham A."/>
        <person name="Scott C.E."/>
        <person name="Howe K.L."/>
        <person name="Woodfine K."/>
        <person name="Spencer C.C.A."/>
        <person name="Jones M.C."/>
        <person name="Gillson C."/>
        <person name="Searle S."/>
        <person name="Zhou Y."/>
        <person name="Kokocinski F."/>
        <person name="McDonald L."/>
        <person name="Evans R."/>
        <person name="Phillips K."/>
        <person name="Atkinson A."/>
        <person name="Cooper R."/>
        <person name="Jones C."/>
        <person name="Hall R.E."/>
        <person name="Andrews T.D."/>
        <person name="Lloyd C."/>
        <person name="Ainscough R."/>
        <person name="Almeida J.P."/>
        <person name="Ambrose K.D."/>
        <person name="Anderson F."/>
        <person name="Andrew R.W."/>
        <person name="Ashwell R.I.S."/>
        <person name="Aubin K."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C.L."/>
        <person name="Bailey J."/>
        <person name="Beasley H."/>
        <person name="Bethel G."/>
        <person name="Bird C.P."/>
        <person name="Bray-Allen S."/>
        <person name="Brown J.Y."/>
        <person name="Brown A.J."/>
        <person name="Buckley D."/>
        <person name="Burton J."/>
        <person name="Bye J."/>
        <person name="Carder C."/>
        <person name="Chapman J.C."/>
        <person name="Clark S.Y."/>
        <person name="Clarke G."/>
        <person name="Clee C."/>
        <person name="Cobley V."/>
        <person name="Collier R.E."/>
        <person name="Corby N."/>
        <person name="Coville G.J."/>
        <person name="Davies J."/>
        <person name="Deadman R."/>
        <person name="Dunn M."/>
        <person name="Earthrowl M."/>
        <person name="Ellington A.G."/>
        <person name="Errington H."/>
        <person name="Frankish A."/>
        <person name="Frankland J."/>
        <person name="French L."/>
        <person name="Garner P."/>
        <person name="Garnett J."/>
        <person name="Gay L."/>
        <person name="Ghori M.R.J."/>
        <person name="Gibson R."/>
        <person name="Gilby L.M."/>
        <person name="Gillett W."/>
        <person name="Glithero R.J."/>
        <person name="Grafham D.V."/>
        <person name="Griffiths C."/>
        <person name="Griffiths-Jones S."/>
        <person name="Grocock R."/>
        <person name="Hammond S."/>
        <person name="Harrison E.S.I."/>
        <person name="Hart E."/>
        <person name="Haugen E."/>
        <person name="Heath P.D."/>
        <person name="Holmes S."/>
        <person name="Holt K."/>
        <person name="Howden P.J."/>
        <person name="Hunt A.R."/>
        <person name="Hunt S.E."/>
        <person name="Hunter G."/>
        <person name="Isherwood J."/>
        <person name="James R."/>
        <person name="Johnson C."/>
        <person name="Johnson D."/>
        <person name="Joy A."/>
        <person name="Kay M."/>
        <person name="Kershaw J.K."/>
        <person name="Kibukawa M."/>
        <person name="Kimberley A.M."/>
        <person name="King A."/>
        <person name="Knights A.J."/>
        <person name="Lad H."/>
        <person name="Laird G."/>
        <person name="Lawlor S."/>
        <person name="Leongamornlert D.A."/>
        <person name="Lloyd D.M."/>
        <person name="Loveland J."/>
        <person name="Lovell J."/>
        <person name="Lush M.J."/>
        <person name="Lyne R."/>
        <person name="Martin S."/>
        <person name="Mashreghi-Mohammadi M."/>
        <person name="Matthews L."/>
        <person name="Matthews N.S.W."/>
        <person name="McLaren S."/>
        <person name="Milne S."/>
        <person name="Mistry S."/>
        <person name="Moore M.J.F."/>
        <person name="Nickerson T."/>
        <person name="O'Dell C.N."/>
        <person name="Oliver K."/>
        <person name="Palmeiri A."/>
        <person name="Palmer S.A."/>
        <person name="Parker A."/>
        <person name="Patel D."/>
        <person name="Pearce A.V."/>
        <person name="Peck A.I."/>
        <person name="Pelan S."/>
        <person name="Phelps K."/>
        <person name="Phillimore B.J."/>
        <person name="Plumb R."/>
        <person name="Rajan J."/>
        <person name="Raymond C."/>
        <person name="Rouse G."/>
        <person name="Saenphimmachak C."/>
        <person name="Sehra H.K."/>
        <person name="Sheridan E."/>
        <person name="Shownkeen R."/>
        <person name="Sims S."/>
        <person name="Skuce C.D."/>
        <person name="Smith M."/>
        <person name="Steward C."/>
        <person name="Subramanian S."/>
        <person name="Sycamore N."/>
        <person name="Tracey A."/>
        <person name="Tromans A."/>
        <person name="Van Helmond Z."/>
        <person name="Wall M."/>
        <person name="Wallis J.M."/>
        <person name="White S."/>
        <person name="Whitehead S.L."/>
        <person name="Wilkinson J.E."/>
        <person name="Willey D.L."/>
        <person name="Williams H."/>
        <person name="Wilming L."/>
        <person name="Wray P.W."/>
        <person name="Wu Z."/>
        <person name="Coulson A."/>
        <person name="Vaudin M."/>
        <person name="Sulston J.E."/>
        <person name="Durbin R.M."/>
        <person name="Hubbard T."/>
        <person name="Wooster R."/>
        <person name="Dunham I."/>
        <person name="Carter N.P."/>
        <person name="McVean G."/>
        <person name="Ross M.T."/>
        <person name="Harrow J."/>
        <person name="Olson M.V."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Bentley D.R."/>
      </authorList>
      <dbReference type="PubMed" id="16710414"/>
      <dbReference type="DOI" id="10.1038/nature04727"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="7">
    <citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <scope>VARIANT ALA-762</scope>
    <source>
      <tissue>Brain</tissue>
    </source>
  </reference>
  <reference key="9">
    <citation type="journal article" date="1990" name="Eur. J. Biochem." volume="194" first="521" last="526">
      <title>Human poly(ADP-ribose) polymerase gene. Cloning of the promoter region.</title>
      <authorList>
        <person name="Yokoyama Y."/>
        <person name="Kawamoto T."/>
        <person name="Mitsuuchi Y."/>
        <person name="Kurosaki T."/>
        <person name="Toda K."/>
        <person name="Ushiro H."/>
        <person name="Terashima M."/>
        <person name="Sumimoto H."/>
        <person name="Kuribayashi I."/>
        <person name="Yamamoto Y."/>
        <person name="Maeda T."/>
        <person name="Ikeda H."/>
        <person name="Sagara Y."/>
        <person name="Shizuta Y."/>
      </authorList>
      <dbReference type="PubMed" id="2125269"/>
      <dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb15647.x"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-95</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="167" first="701" last="710">
      <title>Characterization of a putative promoter region of the human poly(ADP-ribose) polymerase gene: structural similarity to that of the DNA polymerase beta gene.</title>
      <authorList>
        <person name="Ogura T."/>
        <person name="Nyunoya H."/>
        <person name="Takahashi-Masutani M."/>
        <person name="Miwa M."/>
        <person name="Sugimura T."/>
        <person name="Esumi H."/>
      </authorList>
      <dbReference type="PubMed" id="2108670"/>
      <dbReference type="DOI" id="10.1016/0006-291x(90)92082-b"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-40</scope>
  </reference>
  <reference key="11">
    <citation type="submission" date="1991-07" db="EMBL/GenBank/DDBJ databases">
      <title>Human pADPRT is involved in the regulation of its own gene.</title>
      <authorList>
        <person name="Herzog H."/>
        <person name="Schneider R."/>
        <person name="Hirsch-Kauffmann M."/>
        <person name="Schnitzer D."/>
        <person name="Schweiger M."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-40</scope>
  </reference>
  <reference key="12">
    <citation type="submission" date="2008-12" db="UniProtKB">
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Zebisch A."/>
        <person name="Lilla S."/>
        <person name="von Kriegsheim A."/>
        <person name="Lempens A."/>
        <person name="Kolch W."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 2-10; 35-47; 66-78; 109-119; 183-197; 209-221; 263-282; 453-467; 487-496; 529-548; 552-564; 572-582; 637-654; 668-695; 748-761; 780-796; 803-816 AND 859-903</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
    <scope>ACETYLATION AT ALA-2</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
      <tissue>Ovarian carcinoma</tissue>
    </source>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2007" name="Clin. Exp. Immunol." volume="147" first="164" last="175">
      <title>Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells.</title>
      <authorList>
        <person name="Maruyama T."/>
        <person name="Nara K."/>
        <person name="Yoshikawa H."/>
        <person name="Suzuki N."/>
      </authorList>
      <dbReference type="PubMed" id="17177976"/>
      <dbReference type="DOI" id="10.1111/j.1365-2249.2006.03249.x"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 166-177 AND 356-367</scope>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH EEF1A1 AND TXK</scope>
    <scope>PHOSPHORYLATION BY TXK</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="1987" name="Eur. J. Cell Biol." volume="44" first="302" last="307">
      <title>Isolation of a cDNA clone for human NAD+: protein ADP-ribosyltransferase.</title>
      <authorList>
        <person name="Schneider R."/>
        <person name="Auer B."/>
        <person name="Kuhne C."/>
        <person name="Herzog H."/>
        <person name="Klocker H."/>
        <person name="Burtscher H.J."/>
        <person name="Hirsch-Kauffmann M."/>
        <person name="Wintersberger U."/>
        <person name="Schweiger M."/>
      </authorList>
      <dbReference type="PubMed" id="3121332"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 381-420 AND 682-710</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="1987" name="Biochem. Biophys. Res. Commun." volume="146" first="403" last="409">
      <title>Molecular cloning of cDNA for human poly(ADP-ribose) polymerase and expression of its gene during HL-60 cell differentiation.</title>
      <authorList>
        <person name="Suzuki H."/>
        <person name="Uchida K."/>
        <person name="Shima H."/>
        <person name="Sato T."/>
        <person name="Okamoto T."/>
        <person name="Kimura T."/>
        <person name="Miwa M."/>
      </authorList>
      <dbReference type="PubMed" id="3113420"/>
      <dbReference type="DOI" id="10.1016/0006-291x(87)90543-2"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 441-1014</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="1987" name="Biochem. Biophys. Res. Commun." volume="148" first="1549" last="1550">
      <authorList>
        <person name="Suzuki H."/>
        <person name="Uchida K."/>
        <person name="Shima H."/>
        <person name="Sato T."/>
        <person name="Okamoto T."/>
        <person name="Kimura T."/>
        <person name="Miwa M."/>
      </authorList>
    </citation>
    <scope>ERRATUM OF PUBMED:3113420</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="2990" last="2994">
      <title>The second zinc-finger domain of poly(ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA.</title>
      <authorList>
        <person name="Gradwohl G."/>
        <person name="Menissier-de Murcia J."/>
        <person name="Molinete M."/>
        <person name="Simonin F."/>
        <person name="Koken M.H.M."/>
        <person name="Hoeijmakers J.H.J."/>
        <person name="de Murcia G.M."/>
      </authorList>
      <dbReference type="PubMed" id="2109322"/>
      <dbReference type="DOI" id="10.1073/pnas.87.8.2990"/>
    </citation>
    <scope>ANALYSIS OF ZINC-FINGERS</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="21907" last="21913">
      <title>The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNA.</title>
      <authorList>
        <person name="Ikelima M."/>
        <person name="Noguchi S."/>
        <person name="Yamashita R."/>
        <person name="Ogura T."/>
        <person name="Sugimura T."/>
        <person name="Gill D.M."/>
        <person name="Miwa M."/>
      </authorList>
      <dbReference type="PubMed" id="2123876"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(18)45824-3"/>
    </citation>
    <scope>ANALYSIS OF ZINC-FINGERS</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="19249" last="19256">
      <title>Expression and site-directed mutagenesis of the catalytic domain of human poly(ADP-ribose)polymerase in Escherichia coli. Lysine 893 is critical for activity.</title>
      <authorList>
        <person name="Simonin F."/>
        <person name="Menissier-de Murcia J."/>
        <person name="Poch O."/>
        <person name="Muller S."/>
        <person name="Gradwohl G."/>
        <person name="Molinete M."/>
        <person name="Penning C."/>
        <person name="Keith G."/>
        <person name="de Murcia G.M."/>
      </authorList>
      <dbReference type="PubMed" id="2121735"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(17)30651-8"/>
    </citation>
    <scope>MUTAGENESIS OF CATALYTIC DOMAIN</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="1992" name="EMBO J." volume="11" first="3263" last="3269">
      <title>The human poly(ADP-ribose) polymerase nuclear localization signal is a bipartite element functionally separate from DNA binding and catalytic activity.</title>
      <authorList>
        <person name="Schreiber V."/>
        <person name="Molinete M."/>
        <person name="Boeuf H."/>
        <person name="de Murcia G.M."/>
        <person name="Menissier-de Murcia J."/>
      </authorList>
      <dbReference type="PubMed" id="1505517"/>
      <dbReference type="DOI" id="10.1002/j.1460-2075.1992.tb05404.x"/>
    </citation>
    <scope>NUCLEAR LOCALIZATION SIGNAL</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="3247" last="3254">
      <title>Role of glutamic acid 988 of human poly-ADP-ribose polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins.</title>
      <authorList>
        <person name="Marsischky G.T."/>
        <person name="Wilson B.A."/>
        <person name="Collier R.J."/>
      </authorList>
      <dbReference type="PubMed" id="7852410"/>
      <dbReference type="DOI" id="10.1074/jbc.270.7.3247"/>
    </citation>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVE SITE</scope>
    <scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
    <scope>MUTAGENESIS OF HIS-862; GLU-883; GLU-923; GLU-931 AND GLU-988</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="1995" name="Nature" volume="376" first="37" last="43">
      <title>Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.</title>
      <authorList>
        <person name="Nicholson D.W."/>
        <person name="Ali A."/>
        <person name="Thornberry N.A."/>
        <person name="Vaillancourt J.P."/>
        <person name="Ding C.K."/>
        <person name="Gallant M."/>
        <person name="Gareau Y."/>
        <person name="Griffin P.R."/>
        <person name="Labelle M."/>
        <person name="Lazebnik Y.A."/>
        <person name="Munday N.A."/>
        <person name="Raju S.M."/>
        <person name="Smulson M.E."/>
        <person name="Yamin T.-T."/>
        <person name="Li V.L."/>
        <person name="Miller D.K."/>
      </authorList>
      <dbReference type="PubMed" id="7596430"/>
      <dbReference type="DOI" id="10.1038/376037a0"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="1997" name="Biochemistry" volume="36" first="12147" last="12154">
      <title>Random mutagenesis of the poly(ADP-ribose) polymerase catalytic domain reveals amino acids involved in polymer branching.</title>
      <authorList>
        <person name="Rolli V."/>
        <person name="O'Farrell M."/>
        <person name="Menissier-de Murcia J."/>
        <person name="de Murcia G.M."/>
      </authorList>
      <dbReference type="PubMed" id="9315851"/>
      <dbReference type="DOI" id="10.1021/bi971055p"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVE SITE</scope>
    <scope>MUTAGENESIS OF LEU-797; ASN-868; MET-890; LYS-893; PHE-897; ASP-899; CYS-908; LEU-926; TYR-986; GLU-988 AND LEU-1003</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="1998" name="Cancer Res." volume="58" first="3495" last="3498">
      <title>Irreversible binding of poly(ADP)ribose polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis.</title>
      <authorList>
        <person name="Smulson M.E."/>
        <person name="Pang D."/>
        <person name="Jung M."/>
        <person name="Dimtchev A."/>
        <person name="Chasovskikh S."/>
        <person name="Spoonde A."/>
        <person name="Simbulan-Rosenthal C."/>
        <person name="Rosenthal D."/>
        <person name="Yakovlev A."/>
        <person name="Dritschilo A."/>
      </authorList>
      <dbReference type="PubMed" id="9721847"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="1998" name="Nucleic Acids Res." volume="26" first="1891" last="1898">
      <title>Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication.</title>
      <authorList>
        <person name="Dantzer F."/>
        <person name="Nasheuer H.P."/>
        <person name="Vonesch J.L."/>
        <person name="de Murcia G."/>
        <person name="Menissier-de Murcia J."/>
      </authorList>
      <dbReference type="PubMed" id="9518481"/>
      <dbReference type="DOI" id="10.1093/nar/26.8.1891"/>
    </citation>
    <scope>INTERACTION WITH POLA1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="28379" last="28384">
      <title>Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7.</title>
      <authorList>
        <person name="Germain M."/>
        <person name="Affar E.B."/>
        <person name="D'Amours D."/>
        <person name="Dixit V.M."/>
        <person name="Salvesen G.S."/>
        <person name="Poirier G.G."/>
      </authorList>
      <dbReference type="PubMed" id="10497198"/>
      <dbReference type="DOI" id="10.1074/jbc.274.40.28379"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="1999" name="Oncogene" volume="18" first="4616" last="4625">
      <title>Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro.</title>
      <authorList>
        <person name="Ariumi Y."/>
        <person name="Masutani M."/>
        <person name="Copeland T.D."/>
        <person name="Mimori T."/>
        <person name="Sugimura T."/>
        <person name="Shimotohno K."/>
        <person name="Ueda K."/>
        <person name="Hatanaka M."/>
        <person name="Noda M."/>
      </authorList>
      <dbReference type="PubMed" id="10467406"/>
      <dbReference type="DOI" id="10.1038/sj.onc.1202823"/>
    </citation>
    <scope>PHOSPHORYLATION</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2004" name="Cell" volume="119" first="803" last="814">
      <title>NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.</title>
      <authorList>
        <person name="Kim M.Y."/>
        <person name="Mauro S."/>
        <person name="Gevry N."/>
        <person name="Lis J.T."/>
        <person name="Kraus W.L."/>
      </authorList>
      <dbReference type="PubMed" id="15607977"/>
      <dbReference type="DOI" id="10.1016/j.cell.2004.11.002"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH NUCLEOSOMES</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ADP-RIBOSYLATION</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="1081" last="1093">
      <title>Aprataxin, a novel protein that protects against genotoxic stress.</title>
      <authorList>
        <person name="Gueven N."/>
        <person name="Becherel O.J."/>
        <person name="Kijas A.W."/>
        <person name="Chen P."/>
        <person name="Howe O."/>
        <person name="Rudolph J.H."/>
        <person name="Gatti R."/>
        <person name="Date H."/>
        <person name="Onodera O."/>
        <person name="Taucher-Scholz G."/>
        <person name="Lavin M.F."/>
      </authorList>
      <dbReference type="PubMed" id="15044383"/>
      <dbReference type="DOI" id="10.1093/hmg/ddh122"/>
    </citation>
    <scope>INTERACTION WITH APTX</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2006" name="Apoptosis" volume="11" first="131" last="139">
      <title>Nuclear caspase-3 and caspase-7 activation, and poly(ADP-ribose) polymerase cleavage are early events in camptothecin-induced apoptosis.</title>
      <authorList>
        <person name="Rodriguez-Hernandez A."/>
        <person name="Brea-Calvo G."/>
        <person name="Fernandez-Ayala D.J."/>
        <person name="Cordero M."/>
        <person name="Navas P."/>
        <person name="Sanchez-Alcazar J.A."/>
      </authorList>
      <dbReference type="PubMed" id="16374543"/>
      <dbReference type="DOI" id="10.1007/s10495-005-3276-y"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2006" name="Mol. Cell. Endocrinol." volume="257" first="35" last="46">
      <title>The poly(ADP-ribose) polymerase 1 interacts with Sry and modulates its biological functions.</title>
      <authorList>
        <person name="Li Y."/>
        <person name="Oh H.J."/>
        <person name="Lau Y.-F.C."/>
      </authorList>
      <dbReference type="PubMed" id="16904257"/>
      <dbReference type="DOI" id="10.1016/j.mce.2006.06.008"/>
    </citation>
    <scope>INTERACTION WITH SRY</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2007" name="EMBO J." volume="26" first="2094" last="2103">
      <title>A novel human AP endonuclease with conserved zinc-finger-like motifs involved in DNA strand break responses.</title>
      <authorList>
        <person name="Kanno S."/>
        <person name="Kuzuoka H."/>
        <person name="Sasao S."/>
        <person name="Hong Z."/>
        <person name="Lan L."/>
        <person name="Nakajima S."/>
        <person name="Yasui A."/>
      </authorList>
      <dbReference type="PubMed" id="17396150"/>
      <dbReference type="DOI" id="10.1038/sj.emboj.7601663"/>
    </citation>
    <scope>INTERACTION WITH APLF</scope>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
      <title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
      <authorList>
        <person name="Matsuoka S."/>
        <person name="Ballif B.A."/>
        <person name="Smogorzewska A."/>
        <person name="McDonald E.R. III"/>
        <person name="Hurov K.E."/>
        <person name="Luo J."/>
        <person name="Bakalarski C.E."/>
        <person name="Zhao Z."/>
        <person name="Solimini N."/>
        <person name="Lerenthal Y."/>
        <person name="Shiloh Y."/>
        <person name="Gygi S.P."/>
        <person name="Elledge S.J."/>
      </authorList>
      <dbReference type="PubMed" id="17525332"/>
      <dbReference type="DOI" id="10.1126/science.1140321"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Embryonic kidney</tissue>
    </source>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2008" name="Nature" volume="451" first="81" last="85">
      <title>Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.</title>
      <authorList>
        <person name="Ahel I."/>
        <person name="Ahel D."/>
        <person name="Matsusaka T."/>
        <person name="Clark A.J."/>
        <person name="Pines J."/>
        <person name="Boulton S.J."/>
        <person name="West S.C."/>
      </authorList>
      <dbReference type="PubMed" id="18172500"/>
      <dbReference type="DOI" id="10.1038/nature06420"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-368 AND SER-782</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2009" name="Biochem. Pharmacol." volume="77" first="1795" last="1805">
      <title>Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes.</title>
      <authorList>
        <person name="Reinemund J."/>
        <person name="Seidel K."/>
        <person name="Steckelings U.M."/>
        <person name="Zaade D."/>
        <person name="Klare S."/>
        <person name="Rompe F."/>
        <person name="Katerbaum M."/>
        <person name="Schacherl J."/>
        <person name="Li Y."/>
        <person name="Menk M."/>
        <person name="Schefe J.H."/>
        <person name="Goldin-Lang P."/>
        <person name="Szabo C."/>
        <person name="Olah G."/>
        <person name="Unger T."/>
        <person name="Funke-Kaiser H."/>
      </authorList>
      <dbReference type="PubMed" id="19344625"/>
      <dbReference type="DOI" id="10.1016/j.bcp.2009.02.025"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2009" name="EMBO J." volume="28" first="3534" last="3548">
      <title>PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.</title>
      <authorList>
        <person name="Martin N."/>
        <person name="Schwamborn K."/>
        <person name="Schreiber V."/>
        <person name="Werner A."/>
        <person name="Guillier C."/>
        <person name="Zhang X.D."/>
        <person name="Bischof O."/>
        <person name="Seeler J.S."/>
        <person name="Dejean A."/>
      </authorList>
      <dbReference type="PubMed" id="19779455"/>
      <dbReference type="DOI" id="10.1038/emboj.2009.279"/>
    </citation>
    <scope>INTERACTION WITH RNF4</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2009" name="J. Am. Chem. Soc." volume="131" first="14258" last="14260">
      <title>Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications.</title>
      <authorList>
        <person name="Tao Z."/>
        <person name="Gao P."/>
        <person name="Liu H.W."/>
      </authorList>
      <dbReference type="PubMed" id="19764761"/>
      <dbReference type="DOI" id="10.1021/ja906135d"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>MUTAGENESIS OF GLU-988</scope>
    <scope>ADP-RIBOSYLATION AT ASP-387; GLU-488 AND GLU-491</scope>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28660" last="28673">
      <title>The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.</title>
      <authorList>
        <person name="Crawford N.P."/>
        <person name="Yang H."/>
        <person name="Mattaini K.R."/>
        <person name="Hunter K.W."/>
      </authorList>
      <dbReference type="PubMed" id="19710015"/>
      <dbReference type="DOI" id="10.1074/jbc.m109.023457"/>
    </citation>
    <scope>INTERACTION WITH RRP1B</scope>
  </reference>
  <reference key="40">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-782</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="41">
    <citation type="journal article" date="2009" name="Science" volume="325" first="1240" last="1243">
      <title>Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.</title>
      <authorList>
        <person name="Ahel D."/>
        <person name="Horejsi Z."/>
        <person name="Wiechens N."/>
        <person name="Polo S.E."/>
        <person name="Garcia-Wilson E."/>
        <person name="Ahel I."/>
        <person name="Flynn H."/>
        <person name="Skehel M."/>
        <person name="West S.C."/>
        <person name="Jackson S.P."/>
        <person name="Owen-Hughes T."/>
        <person name="Boulton S.J."/>
      </authorList>
      <dbReference type="PubMed" id="19661379"/>
      <dbReference type="DOI" id="10.1126/science.1177321"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>POLY-ADP-RIBOSYLATION</scope>
    <scope>INTERACTION WITH CHD1L</scope>
  </reference>
  <reference key="42">
    <citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
      <title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
      <authorList>
        <person name="Choudhary C."/>
        <person name="Kumar C."/>
        <person name="Gnad F."/>
        <person name="Nielsen M.L."/>
        <person name="Rehman M."/>
        <person name="Walther T.C."/>
        <person name="Olsen J.V."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="19608861"/>
      <dbReference type="DOI" id="10.1126/science.1175371"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-97; LYS-105; LYS-131; LYS-600 AND LYS-621</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="43">
    <citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="8054" last="8060">
      <title>PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.</title>
      <authorList>
        <person name="Loseva O."/>
        <person name="Jemth A.S."/>
        <person name="Bryant H.E."/>
        <person name="Schueler H."/>
        <person name="Lehtioe L."/>
        <person name="Karlberg T."/>
        <person name="Helleday T."/>
      </authorList>
      <dbReference type="PubMed" id="20064938"/>
      <dbReference type="DOI" id="10.1074/jbc.m109.077834"/>
    </citation>
    <scope>INTERACTION WITH PARP3</scope>
  </reference>
  <reference key="44">
    <citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="18877" last="18887">
      <title>The Zn3 domain of human poly(ADP-ribose) polymerase-1 (PARP-1) functions in both DNA-dependent poly(ADP-ribose) synthesis activity and chromatin compaction.</title>
      <authorList>
        <person name="Langelier M.F."/>
        <person name="Ruhl D.D."/>
        <person name="Planck J.L."/>
        <person name="Kraus W.L."/>
        <person name="Pascal J.M."/>
      </authorList>
      <dbReference type="PubMed" id="20388712"/>
      <dbReference type="DOI" id="10.1074/jbc.m110.105668"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>DOMAIN</scope>
    <scope>ADP-RIBOSYLATION</scope>
    <scope>MUTAGENESIS OF GLN-241; ASP-314; VAL-315; THR-316; ALA-317; TRP-318; THR-319; LYS-320; 348-LEU--VAL-350; PHE-357 AND 358-PRO-PRO-359</scope>
  </reference>
  <reference key="45">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-782</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="46">
    <citation type="journal article" date="2010" name="Trends Biochem. Sci." volume="35" first="208" last="219">
      <title>Toward a unified nomenclature for mammalian ADP-ribosyltransferases.</title>
      <authorList>
        <person name="Hottiger M.O."/>
        <person name="Hassa P.O."/>
        <person name="Luscher B."/>
        <person name="Schuler H."/>
        <person name="Koch-Nolte F."/>
      </authorList>
      <dbReference type="PubMed" id="20106667"/>
      <dbReference type="DOI" id="10.1016/j.tibs.2009.12.003"/>
    </citation>
    <scope>NOMENCLATURE</scope>
  </reference>
  <reference key="47">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="48">
    <citation type="journal article" date="2011" name="Cancer Res." volume="71" first="1126" last="1134">
      <title>hPuf-A/KIAA0020 modulates PARP-1 cleavage upon genotoxic stress.</title>
      <authorList>
        <person name="Chang H.Y."/>
        <person name="Fan C.C."/>
        <person name="Chu P.C."/>
        <person name="Hong B.E."/>
        <person name="Lee H.J."/>
        <person name="Chang M.S."/>
      </authorList>
      <dbReference type="PubMed" id="21266351"/>
      <dbReference type="DOI" id="10.1158/0008-5472.can-10-1831"/>
    </citation>
    <scope>INTERACTION WITH PUM3</scope>
  </reference>
  <reference key="49">
    <citation type="journal article" date="2011" name="Oncogene" volume="30" first="4365" last="4372">
      <title>Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.</title>
      <authorList>
        <person name="Rodriguez M.I."/>
        <person name="Gonzalez-Flores A."/>
        <person name="Dantzer F."/>
        <person name="Collard J."/>
        <person name="de Herreros A.G."/>
        <person name="Oliver F.J."/>
      </authorList>
      <dbReference type="PubMed" id="21577210"/>
      <dbReference type="DOI" id="10.1038/onc.2011.153"/>
    </citation>
    <scope>INTERACTION WITH SNAI1</scope>
  </reference>
  <reference key="50">
    <citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E22595" last="E22595">
      <title>Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling.</title>
      <authorList>
        <person name="Callow M.G."/>
        <person name="Tran H."/>
        <person name="Phu L."/>
        <person name="Lau T."/>
        <person name="Lee J."/>
        <person name="Sandoval W.N."/>
        <person name="Liu P.S."/>
        <person name="Bheddah S."/>
        <person name="Tao J."/>
        <person name="Lill J.R."/>
        <person name="Hongo J.A."/>
        <person name="Davis D."/>
        <person name="Kirkpatrick D.S."/>
        <person name="Polakis P."/>
        <person name="Costa M."/>
      </authorList>
      <dbReference type="PubMed" id="21799911"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0022595"/>
    </citation>
    <scope>INTERACTION WITH RNF146</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="51">
    <citation type="journal article" date="2011" name="Science" volume="332" first="1443" last="1446">
      <title>SIRT6 promotes DNA repair under stress by activating PARP1.</title>
      <authorList>
        <person name="Mao Z."/>
        <person name="Hine C."/>
        <person name="Tian X."/>
        <person name="Van Meter M."/>
        <person name="Au M."/>
        <person name="Vaidya A."/>
        <person name="Seluanov A."/>
        <person name="Gorbunova V."/>
      </authorList>
      <dbReference type="PubMed" id="21680843"/>
      <dbReference type="DOI" id="10.1126/science.1202723"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ADP-RIBOSYLATION AT LYS-521</scope>
  </reference>
  <reference key="52">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-782</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="53">
    <citation type="journal article" date="2012" name="Biol. Open" volume="1" first="128" last="139">
      <title>Taperin (c9orf75), a mutated gene in nonsyndromic deafness, encodes a vertebrate specific, nuclear localized protein phosphatase one alpha (PP1alpha) docking protein.</title>
      <authorList>
        <person name="Ferrar T."/>
        <person name="Chamousset D."/>
        <person name="De Wever V."/>
        <person name="Nimick M."/>
        <person name="Andersen J."/>
        <person name="Trinkle-Mulcahy L."/>
        <person name="Moorhead G.B."/>
      </authorList>
      <dbReference type="PubMed" id="23213405"/>
      <dbReference type="DOI" id="10.1242/bio.2011049"/>
    </citation>
    <scope>INTERACTION WITH TPRN</scope>
  </reference>
  <reference key="54">
    <citation type="journal article" date="2012" name="Cell" volume="150" first="533" last="548">
      <title>Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.</title>
      <authorList>
        <person name="Chaki M."/>
        <person name="Airik R."/>
        <person name="Ghosh A.K."/>
        <person name="Giles R.H."/>
        <person name="Chen R."/>
        <person name="Slaats G.G."/>
        <person name="Wang H."/>
        <person name="Hurd T.W."/>
        <person name="Zhou W."/>
        <person name="Cluckey A."/>
        <person name="Gee H.Y."/>
        <person name="Ramaswami G."/>
        <person name="Hong C.J."/>
        <person name="Hamilton B.A."/>
        <person name="Cervenka I."/>
        <person name="Ganji R.S."/>
        <person name="Bryja V."/>
        <person name="Arts H.H."/>
        <person name="van Reeuwijk J."/>
        <person name="Oud M.M."/>
        <person name="Letteboer S.J."/>
        <person name="Roepman R."/>
        <person name="Husson H."/>
        <person name="Ibraghimov-Beskrovnaya O."/>
        <person name="Yasunaga T."/>
        <person name="Walz G."/>
        <person name="Eley L."/>
        <person name="Sayer J.A."/>
        <person name="Schermer B."/>
        <person name="Liebau M.C."/>
        <person name="Benzing T."/>
        <person name="Le Corre S."/>
        <person name="Drummond I."/>
        <person name="Janssen S."/>
        <person name="Allen S.J."/>
        <person name="Natarajan S."/>
        <person name="O'Toole J.F."/>
        <person name="Attanasio M."/>
        <person name="Saunier S."/>
        <person name="Antignac C."/>
        <person name="Koenekoop R.K."/>
        <person name="Ren H."/>
        <person name="Lopez I."/>
        <person name="Nayir A."/>
        <person name="Stoetzel C."/>
        <person name="Dollfus H."/>
        <person name="Massoudi R."/>
        <person name="Gleeson J.G."/>
        <person name="Andreoli S.P."/>
        <person name="Doherty D.G."/>
        <person name="Lindstrad A."/>
        <person name="Golzio C."/>
        <person name="Katsanis N."/>
        <person name="Pape L."/>
        <person name="Abboud E.B."/>
        <person name="Al-Rajhi A.A."/>
        <person name="Lewis R.A."/>
        <person name="Omran H."/>
        <person name="Lee E.Y."/>
        <person name="Wang S."/>
        <person name="Sekiguchi J.M."/>
        <person name="Saunders R."/>
        <person name="Johnson C.A."/>
        <person name="Garner E."/>
        <person name="Vanselow K."/>
        <person name="Andersen J.S."/>
        <person name="Shlomai J."/>
        <person name="Nurnberg G."/>
        <person name="Nurnberg P."/>
        <person name="Levy S."/>
        <person name="Smogorzewska A."/>
        <person name="Otto E.A."/>
        <person name="Hildebrandt F."/>
      </authorList>
      <dbReference type="PubMed" id="22863007"/>
      <dbReference type="DOI" id="10.1016/j.cell.2012.06.028"/>
    </citation>
    <scope>INTERACTION WITH ZNF423</scope>
  </reference>
  <reference key="55">
    <citation type="journal article" date="2012" name="J. Biomed. Sci." volume="19" first="12" last="12">
      <title>Suppressive regulation of KSHV RTA with O-GlcNAcylation.</title>
      <authorList>
        <person name="Ko Y.C."/>
        <person name="Tsai W.H."/>
        <person name="Wang P.W."/>
        <person name="Wu I.L."/>
        <person name="Lin S.Y."/>
        <person name="Chen Y.L."/>
        <person name="Chen J.Y."/>
        <person name="Lin S.F."/>
      </authorList>
      <dbReference type="PubMed" id="22300411"/>
      <dbReference type="DOI" id="10.1186/1423-0127-19-12"/>
    </citation>
    <scope>INTERACTION WITH HUMAN HERPESVIRUS 8 PROTEIN RTA/ORF50 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="56">
    <citation type="journal article" date="2012" name="Mol. Cell" volume="46" first="200" last="211">
      <title>Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-kappaB target genes.</title>
      <authorList>
        <person name="Erener S."/>
        <person name="Petrilli V."/>
        <person name="Kassner I."/>
        <person name="Minotti R."/>
        <person name="Castillo R."/>
        <person name="Santoro R."/>
        <person name="Hassa P.O."/>
        <person name="Tschopp J."/>
        <person name="Hottiger M.O."/>
      </authorList>
      <dbReference type="PubMed" id="22464733"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2012.02.016"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
    <scope>MUTAGENESIS OF ASP-214</scope>
  </reference>
  <reference key="57">
    <citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.013680.01" last="M111.013680.15">
      <title>Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization.</title>
      <authorList>
        <person name="Ahmad Y."/>
        <person name="Boisvert F.M."/>
        <person name="Lundberg E."/>
        <person name="Uhlen M."/>
        <person name="Lamond A.I."/>
      </authorList>
      <dbReference type="PubMed" id="22002106"/>
      <dbReference type="DOI" id="10.1074/mcp.m111.013680"/>
    </citation>
    <scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="58">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="5669" last="5674">
      <title>Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis.</title>
      <authorList>
        <person name="Boucher D."/>
        <person name="Blais V."/>
        <person name="Denault J.B."/>
      </authorList>
      <dbReference type="PubMed" id="22451931"/>
      <dbReference type="DOI" id="10.1073/pnas.1200934109"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
  </reference>
  <reference key="59">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="11800" last="11805">
      <title>Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence.</title>
      <authorList>
        <person name="Mao Z."/>
        <person name="Tian X."/>
        <person name="Van Meter M."/>
        <person name="Ke Z."/>
        <person name="Gorbunova V."/>
        <person name="Seluanov A."/>
      </authorList>
      <dbReference type="PubMed" id="22753495"/>
      <dbReference type="DOI" id="10.1073/pnas.1200583109"/>
    </citation>
    <scope>ADP-RIBOSYLATION</scope>
  </reference>
  <reference key="60">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
      <title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
      <authorList>
        <person name="Van Damme P."/>
        <person name="Lasa M."/>
        <person name="Polevoda B."/>
        <person name="Gazquez C."/>
        <person name="Elosegui-Artola A."/>
        <person name="Kim D.S."/>
        <person name="De Juan-Pardo E."/>
        <person name="Demeyer K."/>
        <person name="Hole K."/>
        <person name="Larrea E."/>
        <person name="Timmerman E."/>
        <person name="Prieto J."/>
        <person name="Arnesen T."/>
        <person name="Sherman F."/>
        <person name="Gevaert K."/>
        <person name="Aldabe R."/>
      </authorList>
      <dbReference type="PubMed" id="22814378"/>
      <dbReference type="DOI" id="10.1073/pnas.1210303109"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="61">
    <citation type="journal article" date="2013" name="Cell Cycle" volume="12" first="2817" last="2828">
      <title>ZNF365 promotes stalled replication forks recovery to maintain genome stability.</title>
      <authorList>
        <person name="Zhang Y."/>
        <person name="Park E."/>
        <person name="Kim C.S."/>
        <person name="Paik J.H."/>
      </authorList>
      <dbReference type="PubMed" id="23966166"/>
      <dbReference type="DOI" id="10.4161/cc.25882"/>
    </citation>
    <scope>INTERACTION WITH ZNF365</scope>
  </reference>
  <reference key="62">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-177; SER-179; SER-185; SER-274; SER-277; SER-782 AND SER-786</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="63">
    <citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="845" last="857">
      <title>BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.</title>
      <authorList>
        <person name="Yan Q."/>
        <person name="Xu R."/>
        <person name="Zhu L."/>
        <person name="Cheng X."/>
        <person name="Wang Z."/>
        <person name="Manis J."/>
        <person name="Shipp M.A."/>
      </authorList>
      <dbReference type="PubMed" id="23230272"/>
      <dbReference type="DOI" id="10.1128/mcb.00990-12"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH PARP9</scope>
  </reference>
  <reference key="64">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="65">
    <citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="4426" last="4426">
      <title>Family-wide analysis of poly(ADP-ribose) polymerase activity.</title>
      <authorList>
        <person name="Vyas S."/>
        <person name="Matic I."/>
        <person name="Uchima L."/>
        <person name="Rood J."/>
        <person name="Zaja R."/>
        <person name="Hay R.T."/>
        <person name="Ahel I."/>
        <person name="Chang P."/>
      </authorList>
      <dbReference type="PubMed" id="25043379"/>
      <dbReference type="DOI" id="10.1038/ncomms5426"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="66">
    <citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
      <title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="D'Souza R.C."/>
        <person name="Yang B."/>
        <person name="Verlaan-de Vries M."/>
        <person name="Mann M."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25218447"/>
      <dbReference type="DOI" id="10.1038/nsmb.2890"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-486; LYS-512 AND LYS-748</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="67">
    <citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="7776" last="7792">
      <title>PARG is dispensable for recovery from transient replicative stress but required to prevent detrimental accumulation of poly(ADP-ribose) upon prolonged replicative stress.</title>
      <authorList>
        <person name="Illuzzi G."/>
        <person name="Fouquerel E."/>
        <person name="Ame J.C."/>
        <person name="Noll A."/>
        <person name="Rehmet K."/>
        <person name="Nasheuer H.P."/>
        <person name="Dantzer F."/>
        <person name="Schreiber V."/>
      </authorList>
      <dbReference type="PubMed" id="24906880"/>
      <dbReference type="DOI" id="10.1093/nar/gku505"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="68">
    <citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
      <title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
      <authorList>
        <person name="Impens F."/>
        <person name="Radoshevich L."/>
        <person name="Cossart P."/>
        <person name="Ribet D."/>
      </authorList>
      <dbReference type="PubMed" id="25114211"/>
      <dbReference type="DOI" id="10.1073/pnas.1413825111"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-203; LYS-486 AND LYS-748</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="69">
    <citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
      <title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Treffers L.W."/>
        <person name="Verlaan-de Vries M."/>
        <person name="Olsen J.V."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25772364"/>
      <dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-203; LYS-467; LYS-486 AND LYS-512</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="70">
    <citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
      <title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
      <authorList>
        <person name="Xiao Z."/>
        <person name="Chang J.G."/>
        <person name="Hendriks I.A."/>
        <person name="Sigurdsson J.O."/>
        <person name="Olsen J.V."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25755297"/>
      <dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="71">
    <citation type="journal article" date="2015" name="Nature" volume="519" first="370" last="373">
      <title>A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol.</title>
      <authorList>
        <person name="Sajish M."/>
        <person name="Schimmel P."/>
      </authorList>
      <dbReference type="PubMed" id="25533949"/>
      <dbReference type="DOI" id="10.1038/nature14028"/>
    </citation>
    <scope>INTERACTION WITH YARS1</scope>
  </reference>
  <reference key="72">
    <citation type="journal article" date="2016" name="Mol. Cell" volume="62" first="432" last="442">
      <title>HPF1/C4orf27 is a PARP-1-interacting protein that regulates PARP-1 ADP-ribosylation activity.</title>
      <authorList>
        <person name="Gibbs-Seymour I."/>
        <person name="Fontana P."/>
        <person name="Rack J.G."/>
        <person name="Ahel I."/>
      </authorList>
      <dbReference type="PubMed" id="27067600"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2016.03.008"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>INTERACTION WITH HPF1</scope>
  </reference>
  <reference key="73">
    <citation type="journal article" date="2016" name="Nucleic Acids Res." volume="44" first="9279" last="9295">
      <title>Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro.</title>
      <authorList>
        <person name="Talhaoui I."/>
        <person name="Lebedeva N.A."/>
        <person name="Zarkovic G."/>
        <person name="Saint-Pierre C."/>
        <person name="Kutuzov M.M."/>
        <person name="Sukhanova M.V."/>
        <person name="Matkarimov B.T."/>
        <person name="Gasparutto D."/>
        <person name="Saparbaev M.K."/>
        <person name="Lavrik O.I."/>
        <person name="Ishchenko A.A."/>
      </authorList>
      <dbReference type="PubMed" id="27471034"/>
      <dbReference type="DOI" id="10.1093/nar/gkw675"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="74">
    <citation type="journal article" date="2016" name="Science" volume="352" first="1221" last="1225">
      <title>ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling.</title>
      <authorList>
        <person name="Wright R.H."/>
        <person name="Lioutas A."/>
        <person name="Le Dily F."/>
        <person name="Soronellas D."/>
        <person name="Pohl A."/>
        <person name="Bonet J."/>
        <person name="Nacht A.S."/>
        <person name="Samino S."/>
        <person name="Font-Mateu J."/>
        <person name="Vicent G.P."/>
        <person name="Wierer M."/>
        <person name="Trabado M.A."/>
        <person name="Schelhorn C."/>
        <person name="Carolis C."/>
        <person name="Macias M.J."/>
        <person name="Yanes O."/>
        <person name="Oliva B."/>
        <person name="Beato M."/>
      </authorList>
      <dbReference type="PubMed" id="27257257"/>
      <dbReference type="DOI" id="10.1126/science.aad9335"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="75">
    <citation type="journal article" date="2017" name="Mol. Cell">
      <title>Serine ADP-ribosylation depends on HPF1.</title>
      <authorList>
        <person name="Bonfiglio J.J."/>
        <person name="Fontana P."/>
        <person name="Zhang Q."/>
        <person name="Colby T."/>
        <person name="Gibbs-Seymour I."/>
        <person name="Atanassov I."/>
        <person name="Bartlett E."/>
        <person name="Zaja R."/>
        <person name="Ahel I."/>
        <person name="Matic I."/>
      </authorList>
      <dbReference type="PubMed" id="28190768"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2017.01.003"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>INTERACTION WITH HPF1</scope>
    <scope>ADP-RIBOSYLATION AT SER-499; SER-507 AND SER-519</scope>
    <scope>MUTAGENESIS OF SER-499; SER-507 AND SER-519</scope>
  </reference>
  <reference key="76">
    <citation type="journal article" date="2017" name="Mol. Cell" volume="68" first="860" last="871">
      <title>A Poly-ADP-Ribose trigger releases the auto-inhibition of a chromatin remodeling oncogene.</title>
      <authorList>
        <person name="Singh H.R."/>
        <person name="Nardozza A.P."/>
        <person name="Moeller I.R."/>
        <person name="Knobloch G."/>
        <person name="Kistemaker H.A.V."/>
        <person name="Hassler M."/>
        <person name="Harrer N."/>
        <person name="Blessing C."/>
        <person name="Eustermann S."/>
        <person name="Kotthoff C."/>
        <person name="Huet S."/>
        <person name="Mueller-Planitz F."/>
        <person name="Filippov D.V."/>
        <person name="Timinszky G."/>
        <person name="Rand K.D."/>
        <person name="Ladurner A.G."/>
      </authorList>
      <dbReference type="PubMed" id="29220653"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2017.11.019"/>
    </citation>
    <scope>INTERACTION WITH CHD1L</scope>
    <scope>MUTAGENESIS OF GLU-988</scope>
  </reference>
  <reference key="77">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-192; LYS-203; LYS-249; LYS-467; LYS-486; LYS-512; LYS-528 AND LYS-748</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="78">
    <citation type="journal article" date="2018" name="Cell Rep." volume="24" first="3488" last="3502">
      <title>Interplay of histone marks with serine ADP-ribosylation.</title>
      <authorList>
        <person name="Bartlett E."/>
        <person name="Bonfiglio J.J."/>
        <person name="Prokhorova E."/>
        <person name="Colby T."/>
        <person name="Zobel F."/>
        <person name="Ahel I."/>
        <person name="Matic I."/>
      </authorList>
      <dbReference type="PubMed" id="30257210"/>
      <dbReference type="DOI" id="10.1016/j.celrep.2018.08.092"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="79">
    <citation type="journal article" date="2018" name="EMBO Rep." volume="19">
      <title>Comprehensive ADP-ribosylome analysis identifies tyrosine as an ADP-ribose acceptor site.</title>
      <authorList>
        <person name="Leslie Pedrioli D.M."/>
        <person name="Leutert M."/>
        <person name="Bilan V."/>
        <person name="Nowak K."/>
        <person name="Gunasekera K."/>
        <person name="Ferrari E."/>
        <person name="Imhof R."/>
        <person name="Malmstroem L."/>
        <person name="Hottiger M.O."/>
      </authorList>
      <dbReference type="PubMed" id="29954836"/>
      <dbReference type="DOI" id="10.15252/embr.201745310"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>INTERACTION WITH HPF1</scope>
    <scope>ADP-RIBOSYLATION AT SER-499; SER-504; SER-507 AND SER-519</scope>
  </reference>
  <reference key="80">
    <citation type="journal article" date="2018" name="Nature" volume="563" first="131" last="136">
      <title>Nuclear cGAS suppresses DNA repair and promotes tumorigenesis.</title>
      <authorList>
        <person name="Liu H."/>
        <person name="Zhang H."/>
        <person name="Wu X."/>
        <person name="Ma D."/>
        <person name="Wu J."/>
        <person name="Wang L."/>
        <person name="Jiang Y."/>
        <person name="Fei Y."/>
        <person name="Zhu C."/>
        <person name="Tan R."/>
        <person name="Jungblut P."/>
        <person name="Pei G."/>
        <person name="Dorhoi A."/>
        <person name="Yan Q."/>
        <person name="Zhang F."/>
        <person name="Zheng R."/>
        <person name="Liu S."/>
        <person name="Liang H."/>
        <person name="Liu Z."/>
        <person name="Yang H."/>
        <person name="Chen J."/>
        <person name="Wang P."/>
        <person name="Tang T."/>
        <person name="Peng W."/>
        <person name="Hu Z."/>
        <person name="Xu Z."/>
        <person name="Huang X."/>
        <person name="Wang J."/>
        <person name="Li H."/>
        <person name="Zhou Y."/>
        <person name="Liu F."/>
        <person name="Yan D."/>
        <person name="Kaufmann S.H.E."/>
        <person name="Chen C."/>
        <person name="Mao Z."/>
        <person name="Ge B."/>
      </authorList>
      <dbReference type="PubMed" id="30356214"/>
      <dbReference type="DOI" id="10.1038/s41586-018-0629-6"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CGAS AND TIMELESS</scope>
  </reference>
  <reference key="81">
    <citation type="journal article" date="2018" name="Nat. Commun." volume="9" first="3233" last="3233">
      <title>PARP2 mediates branched poly ADP-ribosylation in response to DNA damage.</title>
      <authorList>
        <person name="Chen Q."/>
        <person name="Kassab M.A."/>
        <person name="Dantzer F."/>
        <person name="Yu X."/>
      </authorList>
      <dbReference type="PubMed" id="30104678"/>
      <dbReference type="DOI" id="10.1038/s41467-018-05588-5"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF GLU-988</scope>
  </reference>
  <reference key="82">
    <citation type="journal article" date="2019" name="PLoS Biol." volume="17" first="e3000468" last="e3000468">
      <title>KHDC3L mutation causes recurrent pregnancy loss by inducing genomic instability of human early embryonic cells.</title>
      <authorList>
        <person name="Zhang W."/>
        <person name="Chen Z."/>
        <person name="Zhang D."/>
        <person name="Zhao B."/>
        <person name="Liu L."/>
        <person name="Xie Z."/>
        <person name="Yao Y."/>
        <person name="Zheng P."/>
      </authorList>
      <dbReference type="PubMed" id="31609975"/>
      <dbReference type="DOI" id="10.1371/journal.pbio.3000468"/>
    </citation>
    <scope>INTERACTION WITH KHDC3L</scope>
  </reference>
  <reference key="83">
    <citation type="journal article" date="2020" name="Cell" volume="183" first="1086" last="1102">
      <title>An HPF1/PARP1-based chemical biology strategy for exploring ADP-ribosylation.</title>
      <authorList>
        <person name="Bonfiglio J.J."/>
        <person name="Leidecker O."/>
        <person name="Dauben H."/>
        <person name="Longarini E.J."/>
        <person name="Colby T."/>
        <person name="San Segundo-Acosta P."/>
        <person name="Perez K.A."/>
        <person name="Matic I."/>
      </authorList>
      <dbReference type="PubMed" id="33186521"/>
      <dbReference type="DOI" id="10.1016/j.cell.2020.09.055"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ADP-RIBOSYLATION AT SER-499</scope>
  </reference>
  <reference key="84">
    <citation type="journal article" date="2016" name="Cell Rep." volume="16" first="2641" last="2650">
      <title>JNK phosphorylates SIRT6 to stimulate DNA double-strand break repair in response to oxidative stress by recruiting PARP1 to DNA Breaks.</title>
      <authorList>
        <person name="Van Meter M."/>
        <person name="Simon M."/>
        <person name="Tombline G."/>
        <person name="May A."/>
        <person name="Morello T.D."/>
        <person name="Hubbard B.P."/>
        <person name="Bredbenner K."/>
        <person name="Park R."/>
        <person name="Sinclair D.A."/>
        <person name="Bohr V.A."/>
        <person name="Gorbunova V."/>
        <person name="Seluanov A."/>
      </authorList>
      <dbReference type="PubMed" id="27568560"/>
      <dbReference type="DOI" id="10.1016/j.celrep.2016.08.006"/>
    </citation>
    <scope>ADP-RIBOSYLATION AT LYS-521</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="85">
    <citation type="journal article" date="2016" name="Science" volume="353" first="45" last="50">
      <title>Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation.</title>
      <authorList>
        <person name="Gibson B.A."/>
        <person name="Zhang Y."/>
        <person name="Jiang H."/>
        <person name="Hussey K.M."/>
        <person name="Shrimp J.H."/>
        <person name="Lin H."/>
        <person name="Schwede F."/>
        <person name="Yu Y."/>
        <person name="Kraus W.L."/>
      </authorList>
      <dbReference type="PubMed" id="27256882"/>
      <dbReference type="DOI" id="10.1126/science.aaf7865"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="86">
    <citation type="journal article" date="2019" name="Int. J. Cancer" volume="145" first="714" last="727">
      <title>Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.</title>
      <authorList>
        <person name="Chen H.D."/>
        <person name="Chen C.H."/>
        <person name="Wang Y.T."/>
        <person name="Guo N."/>
        <person name="Tian Y.N."/>
        <person name="Huan X.J."/>
        <person name="Song S.S."/>
        <person name="He J.X."/>
        <person name="Miao Z.H."/>
      </authorList>
      <dbReference type="PubMed" id="30675909"/>
      <dbReference type="DOI" id="10.1002/ijc.32131"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ADP-RIBOSYLATION</scope>
  </reference>
  <reference key="87">
    <citation type="journal article" date="2019" name="Nat. Commun." volume="10" first="5751" last="5751">
      <title>PARP1 exhibits enhanced association and catalytic efficiency with gammaH2A.X-nucleosome.</title>
      <authorList>
        <person name="Sharma D."/>
        <person name="De Falco L."/>
        <person name="Padavattan S."/>
        <person name="Rao C."/>
        <person name="Geifman-Shochat S."/>
        <person name="Liu C.F."/>
        <person name="Davey C.A."/>
      </authorList>
      <dbReference type="PubMed" id="31848352"/>
      <dbReference type="DOI" id="10.1038/s41467-019-13641-0"/>
    </citation>
    <scope>INTERACTION WITH NUCLEOSOMES</scope>
  </reference>
  <reference key="88">
    <citation type="journal article" date="2019" name="Nat. Commun." volume="10" first="5501" last="5501">
      <title>Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage.</title>
      <authorList>
        <person name="Bolderson E."/>
        <person name="Burgess J.T."/>
        <person name="Li J."/>
        <person name="Gandhi N.S."/>
        <person name="Boucher D."/>
        <person name="Croft L.V."/>
        <person name="Beard S."/>
        <person name="Plowman J.J."/>
        <person name="Suraweera A."/>
        <person name="Adams M.N."/>
        <person name="Naqi A."/>
        <person name="Zhang S.D."/>
        <person name="Sinclair D.A."/>
        <person name="O'Byrne K.J."/>
        <person name="Richard D.J."/>
      </authorList>
      <dbReference type="PubMed" id="31796734"/>
      <dbReference type="DOI" id="10.1038/s41467-019-13167-5"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH BANF1</scope>
  </reference>
  <reference key="89">
    <citation type="journal article" date="2020" name="Elife" volume="9">
      <title>PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response.</title>
      <authorList>
        <person name="Kim C."/>
        <person name="Wang X.D."/>
        <person name="Yu Y."/>
      </authorList>
      <dbReference type="PubMed" id="32844745"/>
      <dbReference type="DOI" id="10.7554/elife.60637"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
  </reference>
  <reference key="90">
    <citation type="journal article" date="2020" name="Nature" volume="579" first="598" last="602">
      <title>HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.</title>
      <authorList>
        <person name="Suskiewicz M.J."/>
        <person name="Zobel F."/>
        <person name="Ogden T.E.H."/>
        <person name="Fontana P."/>
        <person name="Ariza A."/>
        <person name="Yang J.C."/>
        <person name="Zhu K."/>
        <person name="Bracken L."/>
        <person name="Hawthorne W.J."/>
        <person name="Ahel D."/>
        <person name="Neuhaus D."/>
        <person name="Ahel I."/>
      </authorList>
      <dbReference type="PubMed" id="32028527"/>
      <dbReference type="DOI" id="10.1038/s41586-020-2013-6"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVE SITE</scope>
    <scope>INTERACTION WITH HPF1</scope>
    <scope>MUTAGENESIS OF HIS-826; GLU-988 AND 1013-LEU-TRP-1014</scope>
  </reference>
  <reference key="91">
    <citation type="journal article" date="2020" name="Nat. Commun." volume="11" first="2174" last="2174">
      <title>Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy.</title>
      <authorList>
        <person name="Krueger A."/>
        <person name="Buerkle A."/>
        <person name="Hauser K."/>
        <person name="Mangerich A."/>
      </authorList>
      <dbReference type="PubMed" id="32358582"/>
      <dbReference type="DOI" id="10.1038/s41467-020-15858-w"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ADP-RIBOSYLATION</scope>
  </reference>
  <reference key="92">
    <citation type="journal article" date="2020" name="PLoS Pathog." volume="16" first="e1008474" last="e1008474">
      <title>PARP1-cGAS-NF-kappaB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease.</title>
      <authorList>
        <person name="Choudhuri S."/>
        <person name="Garg N.J."/>
      </authorList>
      <dbReference type="PubMed" id="32315358"/>
      <dbReference type="DOI" id="10.1371/journal.ppat.1008474"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="93">
    <citation type="journal article" date="2021" name="Commun. Biol." volume="4" first="1259" last="1259">
      <title>Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.</title>
      <authorList>
        <person name="Kurgina T.A."/>
        <person name="Moor N.A."/>
        <person name="Kutuzov M.M."/>
        <person name="Naumenko K.N."/>
        <person name="Ukraintsev A.A."/>
        <person name="Lavrik O.I."/>
      </authorList>
      <dbReference type="PubMed" id="34732825"/>
      <dbReference type="DOI" id="10.1038/s42003-021-02780-0"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="94">
    <citation type="journal article" date="2021" name="DNA Repair" volume="104" first="103132" last="103132">
      <title>PARP1-mediated PARylation of TonEBP prevents R-loop-associated DNA damage.</title>
      <authorList>
        <person name="Ye B.J."/>
        <person name="Kang H.J."/>
        <person name="Lee-Kwon W."/>
        <person name="Kwon H.M."/>
        <person name="Choi S.Y."/>
      </authorList>
      <dbReference type="PubMed" id="34049076"/>
      <dbReference type="DOI" id="10.1016/j.dnarep.2021.103132"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="95">
    <citation type="journal article" date="2021" name="Elife" volume="10">
      <title>HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.</title>
      <authorList>
        <person name="Rudolph J."/>
        <person name="Roberts G."/>
        <person name="Muthurajan U.M."/>
        <person name="Luger K."/>
      </authorList>
      <dbReference type="PubMed" id="33683197"/>
      <dbReference type="DOI" id="10.7554/elife.65773"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="96">
    <citation type="journal article" date="2021" name="Elife" volume="10">
      <title>Serine ADP-ribosylation marks nucleosomes for ALC1-dependent chromatin remodeling.</title>
      <authorList>
        <person name="Mohapatra J."/>
        <person name="Tashiro K."/>
        <person name="Beckner R.L."/>
        <person name="Sierra J."/>
        <person name="Kilgore J.A."/>
        <person name="Williams N.S."/>
        <person name="Liszczak G."/>
      </authorList>
      <dbReference type="PubMed" id="34874266"/>
      <dbReference type="DOI" id="10.7554/elife.71502"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="97">
    <citation type="journal article" date="2021" name="J. Biol. Chem." volume="296" first="100046" last="100046">
      <title>The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis.</title>
      <authorList>
        <person name="Mashimo M."/>
        <person name="Onishi M."/>
        <person name="Uno A."/>
        <person name="Tanimichi A."/>
        <person name="Nobeyama A."/>
        <person name="Mori M."/>
        <person name="Yamada S."/>
        <person name="Negi S."/>
        <person name="Bu X."/>
        <person name="Kato J."/>
        <person name="Moss J."/>
        <person name="Sanada N."/>
        <person name="Kizu R."/>
        <person name="Fujii T."/>
      </authorList>
      <dbReference type="PubMed" id="33168626"/>
      <dbReference type="DOI" id="10.1074/jbc.ra120.014479"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>FUNCTION (POLY [ADP-RIBOSE] POLYMERASE 1</scope>
    <scope>PROCESSED C-TERMINUS)</scope>
    <scope>INTERACTION WITH AIFM1</scope>
  </reference>
  <reference key="98">
    <citation type="journal article" date="2021" name="Mol. Cell" volume="81" first="784" last="800">
      <title>CARM1 regulates replication fork speed and stress response by stimulating PARP1.</title>
      <authorList>
        <person name="Genois M.M."/>
        <person name="Gagne J.P."/>
        <person name="Yasuhara T."/>
        <person name="Jackson J."/>
        <person name="Saxena S."/>
        <person name="Langelier M.F."/>
        <person name="Ahel I."/>
        <person name="Bedford M.T."/>
        <person name="Pascal J.M."/>
        <person name="Vindigni A."/>
        <person name="Poirier G.G."/>
        <person name="Zou L."/>
      </authorList>
      <dbReference type="PubMed" id="33412112"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2020.12.010"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH CARM1</scope>
  </reference>
  <reference key="99">
    <citation type="journal article" date="2021" name="Mol. Cell" volume="81" first="3018" last="3030">
      <title>XRCC1 prevents toxic PARP1 trapping during DNA base excision repair.</title>
      <authorList>
        <person name="Demin A.A."/>
        <person name="Hirota K."/>
        <person name="Tsuda M."/>
        <person name="Adamowicz M."/>
        <person name="Hailstone R."/>
        <person name="Brazina J."/>
        <person name="Gittens W."/>
        <person name="Kalasova I."/>
        <person name="Shao Z."/>
        <person name="Zha S."/>
        <person name="Sasanuma H."/>
        <person name="Hanzlikova H."/>
        <person name="Takeda S."/>
        <person name="Caldecott K.W."/>
      </authorList>
      <dbReference type="PubMed" id="34102106"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2021.05.009"/>
    </citation>
    <scope>INTERACTION WITH XRCC1</scope>
  </reference>
  <reference key="100">
    <citation type="journal article" date="2021" name="Nat. Cell Biol." volume="23" first="1287" last="1298">
      <title>XRCC1 protects transcription from toxic PARP1 activity during DNA base excision repair.</title>
      <authorList>
        <person name="Adamowicz M."/>
        <person name="Hailstone R."/>
        <person name="Demin A.A."/>
        <person name="Komulainen E."/>
        <person name="Hanzlikova H."/>
        <person name="Brazina J."/>
        <person name="Gautam A."/>
        <person name="Wells S.E."/>
        <person name="Caldecott K.W."/>
      </authorList>
      <dbReference type="PubMed" id="34811483"/>
      <dbReference type="DOI" id="10.1038/s41556-021-00792-w"/>
    </citation>
    <scope>INTERACTION WITH XRCC1</scope>
  </reference>
  <reference key="101">
    <citation type="journal article" date="2021" name="Nat. Commun." volume="12" first="4055" last="4055">
      <title>Serine-linked PARP1 auto-modification controls PARP inhibitor response.</title>
      <authorList>
        <person name="Prokhorova E."/>
        <person name="Zobel F."/>
        <person name="Smith R."/>
        <person name="Zentout S."/>
        <person name="Gibbs-Seymour I."/>
        <person name="Schuetzenhofer K."/>
        <person name="Peters A."/>
        <person name="Groslambert J."/>
        <person name="Zorzini V."/>
        <person name="Agnew T."/>
        <person name="Brognard J."/>
        <person name="Nielsen M.L."/>
        <person name="Ahel D."/>
        <person name="Huet S."/>
        <person name="Suskiewicz M.J."/>
        <person name="Ahel I."/>
      </authorList>
      <dbReference type="PubMed" id="34210965"/>
      <dbReference type="DOI" id="10.1038/s41467-021-24361-9"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>ADP-RIBOSYLATION AT SER-499; SER-507 AND SER-519</scope>
  </reference>
  <reference key="102">
    <citation type="journal article" date="2021" name="Nat. Commun." volume="12" first="5893" last="5893">
      <title>The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Buch-Larsen S.C."/>
        <person name="Prokhorova E."/>
        <person name="Elsborg J.D."/>
        <person name="Rebak A.K.L.F.S."/>
        <person name="Zhu K."/>
        <person name="Ahel D."/>
        <person name="Lukas C."/>
        <person name="Ahel I."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="34625544"/>
      <dbReference type="DOI" id="10.1038/s41467-021-26172-4"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ADP-RIBOSYLATION AT SER-499; SER-507 AND SER-519</scope>
    <scope>MUTAGENESIS OF SER-499; SER-507 AND SER-519</scope>
  </reference>
  <reference key="103">
    <citation type="journal article" date="2021" name="Nat. Commun." volume="12" first="6362" last="6362">
      <title>SPINDOC binds PARP1 to facilitate PARylation.</title>
      <authorList>
        <person name="Yang F."/>
        <person name="Chen J."/>
        <person name="Liu B."/>
        <person name="Gao G."/>
        <person name="Sebastian M."/>
        <person name="Jeter C."/>
        <person name="Shen J."/>
        <person name="Person M.D."/>
        <person name="Bedford M.T."/>
      </authorList>
      <dbReference type="PubMed" id="34737271"/>
      <dbReference type="DOI" id="10.1038/s41467-021-26588-y"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH SPINDOC</scope>
  </reference>
  <reference key="104">
    <citation type="journal article" date="2021" name="Nat. Commun." volume="12" first="6675" last="6675">
      <title>HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.</title>
      <authorList>
        <person name="Langelier M.F."/>
        <person name="Billur R."/>
        <person name="Sverzhinsky A."/>
        <person name="Black B.E."/>
        <person name="Pascal J.M."/>
      </authorList>
      <dbReference type="PubMed" id="34795260"/>
      <dbReference type="DOI" id="10.1038/s41467-021-27043-8"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF HIS-826 AND ARG-865</scope>
  </reference>
  <reference key="105">
    <citation type="journal article" date="2021" name="Proc. Natl. Acad. Sci. U.S.A." volume="118">
      <title>Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.</title>
      <authorList>
        <person name="Ooi S.K."/>
        <person name="Sato S."/>
        <person name="Tomomori-Sato C."/>
        <person name="Zhang Y."/>
        <person name="Wen Z."/>
        <person name="Banks C.A.S."/>
        <person name="Washburn M.P."/>
        <person name="Unruh J.R."/>
        <person name="Florens L."/>
        <person name="Conaway R.C."/>
        <person name="Conaway J.W."/>
      </authorList>
      <dbReference type="PubMed" id="34465625"/>
      <dbReference type="DOI" id="10.1073/pnas.2107277118"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="106">
    <citation type="journal article" date="2022" name="Genes Cells" volume="27" first="305" last="312">
      <title>PARP1 is activated by membrane damage and is involved in membrane repair through poly(ADP-ribosyl)ation.</title>
      <authorList>
        <person name="Mashimo M."/>
        <person name="Kita M."/>
        <person name="Nobeyama A."/>
        <person name="Nomura A."/>
        <person name="Fujii T."/>
      </authorList>
      <dbReference type="PubMed" id="35124853"/>
      <dbReference type="DOI" id="10.1111/gtc.12926"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="107">
    <citation type="journal article" date="2022" name="J. Clin. Invest." volume="132">
      <title>RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1.</title>
      <authorList>
        <person name="Abu-Libdeh B."/>
        <person name="Jhujh S.S."/>
        <person name="Dhar S."/>
        <person name="Sommers J.A."/>
        <person name="Datta A."/>
        <person name="Longo G.M."/>
        <person name="Grange L.J."/>
        <person name="Reynolds J.J."/>
        <person name="Cooke S.L."/>
        <person name="McNee G.S."/>
        <person name="Hollingworth R."/>
        <person name="Woodward B.L."/>
        <person name="Ganesh A.N."/>
        <person name="Smerdon S.J."/>
        <person name="Nicolae C.M."/>
        <person name="Durlacher-Betzer K."/>
        <person name="Molho-Pessach V."/>
        <person name="Abu-Libdeh A."/>
        <person name="Meiner V."/>
        <person name="Moldovan G.L."/>
        <person name="Roukos V."/>
        <person name="Harel T."/>
        <person name="Brosh R.M. Jr."/>
        <person name="Stewart G.S."/>
      </authorList>
      <dbReference type="PubMed" id="35025765"/>
      <dbReference type="DOI" id="10.1172/jci147301"/>
    </citation>
    <scope>INTERACTION WITH RECQL</scope>
  </reference>
  <reference key="108">
    <citation type="journal article" date="2022" name="Mol. Cell" volume="82" first="785" last="802">
      <title>SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage.</title>
      <authorList>
        <person name="Meza-Sosa K.F."/>
        <person name="Miao R."/>
        <person name="Navarro F."/>
        <person name="Zhang Z."/>
        <person name="Zhang Y."/>
        <person name="Hu J.J."/>
        <person name="Hartford C.C.R."/>
        <person name="Li X.L."/>
        <person name="Pedraza-Alva G."/>
        <person name="Perez-Martinez L."/>
        <person name="Lal A."/>
        <person name="Wu H."/>
        <person name="Lieberman J."/>
      </authorList>
      <dbReference type="PubMed" id="35104452"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2022.01.001"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE</scope>
    <scope>FUNCTION (POLY [ADP-RIBOSE] POLYMERASE 1</scope>
    <scope>PROCESSED N-TERMINUS)</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="109">
    <citation type="journal article" date="2022" name="Mol. Cell" volume="82" first="1297" last="1312">
      <title>Micropeptide PACMP inhibition elicits synthetic lethal effects by decreasing CtIP and poly(ADP-ribosyl)ation.</title>
      <authorList>
        <person name="Zhang C."/>
        <person name="Zhou B."/>
        <person name="Gu F."/>
        <person name="Liu H."/>
        <person name="Wu H."/>
        <person name="Yao F."/>
        <person name="Zheng H."/>
        <person name="Fu H."/>
        <person name="Chong W."/>
        <person name="Cai S."/>
        <person name="Huang M."/>
        <person name="Ma X."/>
        <person name="Guo Z."/>
        <person name="Li T."/>
        <person name="Deng W."/>
        <person name="Zheng M."/>
        <person name="Ji Q."/>
        <person name="Zhao Y."/>
        <person name="Ma Y."/>
        <person name="Wang Q.E."/>
        <person name="Tang T.S."/>
        <person name="Guo C."/>
      </authorList>
      <dbReference type="PubMed" id="35219381"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2022.01.020"/>
    </citation>
    <scope>INTERACTION WITH PACMP</scope>
  </reference>
  <reference key="110">
    <citation type="journal article" date="2022" name="Mol. Cell">
      <title>Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS.</title>
      <authorList>
        <person name="Wang F."/>
        <person name="Zhao M."/>
        <person name="Chang B."/>
        <person name="Zhou Y."/>
        <person name="Wu X."/>
        <person name="Ma M."/>
        <person name="Liu S."/>
        <person name="Cao Y."/>
        <person name="Zheng M."/>
        <person name="Dang Y."/>
        <person name="Xu J."/>
        <person name="Chen L."/>
        <person name="Liu T."/>
        <person name="Tang F."/>
        <person name="Ren Y."/>
        <person name="Xu Z."/>
        <person name="Mao Z."/>
        <person name="Huang K."/>
        <person name="Luo M."/>
        <person name="Li J."/>
        <person name="Liu H."/>
        <person name="Ge B."/>
      </authorList>
      <dbReference type="PubMed" id="35460603"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2022.03.034"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>PHOSPHORYLATION AT THR-594</scope>
    <scope>MUTAGENESIS OF SER-25; THR-325 AND THR-594</scope>
  </reference>
  <reference key="111">
    <citation type="journal article" date="2022" name="Nat. Cell Biol." volume="24" first="62" last="73">
      <title>The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.</title>
      <authorList>
        <person name="Krastev D.B."/>
        <person name="Li S."/>
        <person name="Sun Y."/>
        <person name="Wicks A.J."/>
        <person name="Hoslett G."/>
        <person name="Weekes D."/>
        <person name="Badder L.M."/>
        <person name="Knight E.G."/>
        <person name="Marlow R."/>
        <person name="Pardo M.C."/>
        <person name="Yu L."/>
        <person name="Talele T.T."/>
        <person name="Bartek J."/>
        <person name="Choudhary J.S."/>
        <person name="Pommier Y."/>
        <person name="Pettitt S.J."/>
        <person name="Tutt A.N.J."/>
        <person name="Ramadan K."/>
        <person name="Lord C.J."/>
      </authorList>
      <dbReference type="PubMed" id="35013556"/>
      <dbReference type="DOI" id="10.1038/s41556-021-00807-6"/>
    </citation>
    <scope>ACTIVITY REGULATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>SUMOYLATION</scope>
    <scope>UBIQUITINATION</scope>
    <scope>INTERACTION WITH VCP</scope>
    <scope>MUTAGENESIS OF 119-LYS-SER-120</scope>
  </reference>
  <reference key="112">
    <citation type="journal article" date="2022" name="Nat. Cell Biol." volume="24" first="513" last="525">
      <title>Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage.</title>
      <authorList>
        <person name="Fu H."/>
        <person name="Liu R."/>
        <person name="Jia Z."/>
        <person name="Li R."/>
        <person name="Zhu F."/>
        <person name="Zhu W."/>
        <person name="Shao Y."/>
        <person name="Jin Y."/>
        <person name="Xue Y."/>
        <person name="Huang J."/>
        <person name="Luo K."/>
        <person name="Gao X."/>
        <person name="Lu H."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="35393539"/>
      <dbReference type="DOI" id="10.1038/s41556-022-00872-5"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="113">
    <citation type="journal article" date="2023" name="Nucleic Acids Res.">
      <title>ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance.</title>
      <authorList>
        <person name="O'Sullivan J."/>
        <person name="Kothari C."/>
        <person name="Caron M.C."/>
        <person name="Gagne J.P."/>
        <person name="Jin Z."/>
        <person name="Nonfoux L."/>
        <person name="Beneyton A."/>
        <person name="Coulombe Y."/>
        <person name="Thomas M."/>
        <person name="Atalay N."/>
        <person name="Meng X.W."/>
        <person name="Milano L."/>
        <person name="Jean D."/>
        <person name="Boisvert F.M."/>
        <person name="Kaufmann S.H."/>
        <person name="Hendzel M.J."/>
        <person name="Masson J.Y."/>
        <person name="Poirier G.G."/>
      </authorList>
      <dbReference type="PubMed" id="37823600"/>
      <dbReference type="DOI" id="10.1093/nar/gkad791"/>
    </citation>
    <scope>INTERACTION WITH ZNF432</scope>
  </reference>
  <reference key="114">
    <citation type="submission" date="2007-04" db="PDB data bank">
      <title>Solution structure of the first ZF-PARP domain, of the BRCT domain and of the WGR domain of human poly(ADP-ribose)polymerase-1.</title>
      <authorList>
        <consortium name="RIKEN structural genomics initiative (RSGI)"/>
      </authorList>
    </citation>
    <scope>STRUCTURE BY NMR OF 1-93 AND 385-643</scope>
  </reference>
  <reference evidence="127" key="115">
    <citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="4105" last="4114">
      <title>A third zinc-binding domain of human poly(ADP-ribose) polymerase-1 coordinates DNA-dependent enzyme activation.</title>
      <authorList>
        <person name="Langelier M.F."/>
        <person name="Servent K.M."/>
        <person name="Rogers E.E."/>
        <person name="Pascal J.M."/>
      </authorList>
      <dbReference type="PubMed" id="18055453"/>
      <dbReference type="DOI" id="10.1074/jbc.m708558200"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 216-366 IN COMPLEX WITH ZINC</scope>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF CYS-298</scope>
  </reference>
  <reference evidence="128 129 130 131" key="116">
    <citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="10690" last="10701">
      <title>Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity.</title>
      <authorList>
        <person name="Langelier M.F."/>
        <person name="Planck J.L."/>
        <person name="Roy S."/>
        <person name="Pascal J.M."/>
      </authorList>
      <dbReference type="PubMed" id="21233213"/>
      <dbReference type="DOI" id="10.1074/jbc.m110.202507"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 2-96 IN COMPLEX WITH ZINC</scope>
    <scope>MUTAGENESIS OF ARG-18; ARG-34; GLN-40; SER-41; PRO-42; MET-43; 44-PHE--VAL-48; PHE-44; ASP-45; ARG-122 AND 151-LEU--ILE-154</scope>
  </reference>
  <reference evidence="132" key="117">
    <citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="685" last="692">
      <title>The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks.</title>
      <authorList>
        <person name="Ali A.A.E."/>
        <person name="Timinszky G."/>
        <person name="Arribas-Bosacoma R."/>
        <person name="Kozlowski M."/>
        <person name="Hassa P.O."/>
        <person name="Hassler M."/>
        <person name="Ladurner A.G."/>
        <person name="Pearl L.H."/>
        <person name="Oliver A.W."/>
      </authorList>
      <dbReference type="PubMed" id="22683995"/>
      <dbReference type="DOI" id="10.1038/nsmb.2335"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 5-202 IN COMPLEX WITH ZINC</scope>
    <scope>SUBUNIT</scope>
    <scope>DOMAIN</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF ARG-34; MET-43; PHE-44 AND ARG-138</scope>
  </reference>
  <reference evidence="133" key="118">
    <citation type="journal article" date="2012" name="Science" volume="336" first="728" last="732">
      <title>Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1.</title>
      <authorList>
        <person name="Langelier M.F."/>
        <person name="Planck J.L."/>
        <person name="Roy S."/>
        <person name="Pascal J.M."/>
      </authorList>
      <dbReference type="PubMed" id="22582261"/>
      <dbReference type="DOI" id="10.1126/science.1216338"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 1-96; 216-366 AND 518-1014 IN COMPLEX WITH ZINC</scope>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>ADP-RIBOSYLATION</scope>
    <scope>MUTAGENESIS OF ASP-45; TRP-246; TRP-318; ASN-567; TRP-589; ARG-591; LYS-633; 698-LEU--LEU-701; LEU-713; LEU-765 AND LEU-768</scope>
  </reference>
  <reference evidence="137" key="119">
    <citation type="journal article" date="2015" name="Mol. Cell" volume="60" first="163" last="176">
      <title>Timeless interacts with PARP-1 to promote homologous recombination repair.</title>
      <authorList>
        <person name="Xie S."/>
        <person name="Mortusewicz O."/>
        <person name="Ma H.T."/>
        <person name="Herr P."/>
        <person name="Poon R.Y."/>
        <person name="Helleday T."/>
        <person name="Qian C."/>
      </authorList>
      <dbReference type="PubMed" id="26344098"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2015.07.031"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 661-1014 IN COMPLEX WITH TIMELESS</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>INTERACTION WITH TIMELESS</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF 490-VAL--VAL-493; 850-PRO-PHE-851 AND ASP-993</scope>
  </reference>
  <reference evidence="126" key="120">
    <citation type="journal article" date="2015" name="Mol. Cell" volume="60" first="742" last="754">
      <title>Structural basis of detection and signaling of DNA single-strand breaks by human PARP-1.</title>
      <authorList>
        <person name="Eustermann S."/>
        <person name="Wu W.F."/>
        <person name="Langelier M.F."/>
        <person name="Yang J.C."/>
        <person name="Easton L.E."/>
        <person name="Riccio A.A."/>
        <person name="Pascal J.M."/>
        <person name="Neuhaus D."/>
      </authorList>
      <dbReference type="PubMed" id="26626479"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2015.10.032"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 1-214</scope>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>DOMAIN</scope>
    <scope>MUTAGENESIS OF TRP-246; TRP-318; ASN-567; TRP-589; ARG-591 AND LYS-633</scope>
  </reference>
  <reference evidence="138" key="121">
    <citation type="journal article" date="2015" name="Mol. Cell" volume="60" first="755" last="768">
      <title>PARP-1 activation requires local unfolding of an autoinhibitory domain.</title>
      <authorList>
        <person name="Dawicki-McKenna J.M."/>
        <person name="Langelier M.F."/>
        <person name="DeNizio J.E."/>
        <person name="Riccio A.A."/>
        <person name="Cao C.D."/>
        <person name="Karch K.R."/>
        <person name="McCauley M."/>
        <person name="Steffen J.D."/>
        <person name="Black B.E."/>
        <person name="Pascal J.M."/>
      </authorList>
      <dbReference type="PubMed" id="26626480"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2015.10.013"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 788-1012</scope>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>DOMAIN</scope>
    <scope>MUTAGENESIS OF TRP-318; LEU-713; ALA-774; ALA-870; GLY-871; PRO-882; 883-GLU--THR-887 AND PRO-885</scope>
  </reference>
  <reference evidence="139" key="122">
    <citation type="journal article" date="2018" name="Nat. Commun." volume="9" first="844" last="844">
      <title>NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains.</title>
      <authorList>
        <person name="Langelier M.F."/>
        <person name="Zandarashvili L."/>
        <person name="Aguiar P.M."/>
        <person name="Black B.E."/>
        <person name="Pascal J.M."/>
      </authorList>
      <dbReference type="PubMed" id="29487285"/>
      <dbReference type="DOI" id="10.1038/s41467-018-03234-8"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 788-1012 IN COMPLEX WITH PARP INHIBITOR BAD</scope>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>MUTAGENESIS OF 763-GLU--ASP-770</scope>
  </reference>
  <reference evidence="141 142 143 144" key="123">
    <citation type="journal article" date="2020" name="Science" volume="368">
      <title>Structural basis for allosteric PARP-1 retention on DNA breaks.</title>
      <authorList>
        <person name="Zandarashvili L."/>
        <person name="Langelier M.F."/>
        <person name="Velagapudi U.K."/>
        <person name="Hancock M.A."/>
        <person name="Steffen J.D."/>
        <person name="Billur R."/>
        <person name="Hannan Z.M."/>
        <person name="Wicks A.J."/>
        <person name="Krastev D.B."/>
        <person name="Pettitt S.J."/>
        <person name="Lord C.J."/>
        <person name="Talele T.T."/>
        <person name="Pascal J.M."/>
        <person name="Black B.E."/>
      </authorList>
      <dbReference type="PubMed" id="32241924"/>
      <dbReference type="DOI" id="10.1126/science.aax6367"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 788-1012 IN COMPLEX WITH PARP INHIBITORS UKTT15; EB-47 AND RUCAPARIB</scope>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>MUTAGENESIS OF TRP-318 AND 766-ASP--ASP-770</scope>
  </reference>
  <reference evidence="145 146 147 148 149" key="124">
    <citation type="journal article" date="2021" name="J. Biol. Chem." volume="296" first="100251" last="100251">
      <title>Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1.</title>
      <authorList>
        <person name="Ryan K."/>
        <person name="Bolanos B."/>
        <person name="Smith M."/>
        <person name="Palde P.B."/>
        <person name="Cuenca P.D."/>
        <person name="VanArsdale T.L."/>
        <person name="Niessen S."/>
        <person name="Zhang L."/>
        <person name="Behenna D."/>
        <person name="Ornelas M.A."/>
        <person name="Tran K.T."/>
        <person name="Kaiser S."/>
        <person name="Lum L."/>
        <person name="Stewart A."/>
        <person name="Gajiwala K.S."/>
      </authorList>
      <dbReference type="PubMed" id="33361107"/>
      <dbReference type="DOI" id="10.1074/jbc.ra120.016573"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 662-1011 IN COMPLEX WITH TALAZOPARIB; OLAPARIB; NIRAPARIB AND VELIPARIB INHIBITORS</scope>
    <scope>ACTIVITY REGULATION</scope>
  </reference>
  <reference evidence="150 151" key="125">
    <citation type="journal article" date="2021" name="Mol. Cell" volume="81" first="4994" last="5006">
      <title>The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer.</title>
      <authorList>
        <person name="Rudolph J."/>
        <person name="Muthurajan U.M."/>
        <person name="Palacio M."/>
        <person name="Mahadevan J."/>
        <person name="Roberts G."/>
        <person name="Erbse A.H."/>
        <person name="Dyer P.N."/>
        <person name="Luger K."/>
      </authorList>
      <dbReference type="PubMed" id="34919819"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2021.11.014"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF 385-492 IN COMPLEX WITH DNA</scope>
    <scope>DOMAIN</scope>
    <scope>MUTAGENESIS OF LYS-394; 405-LYS--LYS-409; 418-LYS--LYS-425; LYS-418; 441-LYS-LYS-442 AND TRP-589</scope>
  </reference>
  <reference evidence="140" key="126">
    <citation type="journal article" date="2021" name="Nat. Commun." volume="12" first="1028" last="1028">
      <title>HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.</title>
      <authorList>
        <person name="Sun F.H."/>
        <person name="Zhao P."/>
        <person name="Zhang N."/>
        <person name="Kong L.L."/>
        <person name="Wong C.C.L."/>
        <person name="Yun C.H."/>
      </authorList>
      <dbReference type="PubMed" id="33589610"/>
      <dbReference type="DOI" id="10.1038/s41467-021-21302-4"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 788-1014 IN COMPLEX WITH HPF1</scope>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH HPF1</scope>
  </reference>
  <reference key="127">
    <citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
      <title>The consensus coding sequences of human breast and colorectal cancers.</title>
      <authorList>
        <person name="Sjoeblom T."/>
        <person name="Jones S."/>
        <person name="Wood L.D."/>
        <person name="Parsons D.W."/>
        <person name="Lin J."/>
        <person name="Barber T.D."/>
        <person name="Mandelker D."/>
        <person name="Leary R.J."/>
        <person name="Ptak J."/>
        <person name="Silliman N."/>
        <person name="Szabo S."/>
        <person name="Buckhaults P."/>
        <person name="Farrell C."/>
        <person name="Meeh P."/>
        <person name="Markowitz S.D."/>
        <person name="Willis J."/>
        <person name="Dawson D."/>
        <person name="Willson J.K.V."/>
        <person name="Gazdar A.F."/>
        <person name="Hartigan J."/>
        <person name="Wu L."/>
        <person name="Liu C."/>
        <person name="Parmigiani G."/>
        <person name="Park B.H."/>
        <person name="Bachman K.E."/>
        <person name="Papadopoulos N."/>
        <person name="Vogelstein B."/>
        <person name="Kinzler K.W."/>
        <person name="Velculescu V.E."/>
      </authorList>
      <dbReference type="PubMed" id="16959974"/>
      <dbReference type="DOI" id="10.1126/science.1133427"/>
    </citation>
    <scope>VARIANT [LARGE SCALE ANALYSIS] VAL-488</scope>
  </reference>
  <comment type="function">
    <text evidence="1 17 21 22 23 24 25 26 28 32 36 40 41 46 48 49 51 52 53 54 55 56 57 59 63 64 65 66 69 71 72 73 74 75 77 79 80 81 82 85 86 87 88 89 91 96 98 99 102 103">Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair (PubMed:17177976, PubMed:18055453, PubMed:18172500, PubMed:19344625, PubMed:19661379, PubMed:20388712, PubMed:21680843, PubMed:22582261, PubMed:23230272, PubMed:25043379, PubMed:26344098, PubMed:26626479, PubMed:26626480, PubMed:30104678, PubMed:31796734, PubMed:32028527, PubMed:32241924, PubMed:32358582, PubMed:33186521, PubMed:34465625, PubMed:34737271). Mediates glutamate, aspartate, serine, histidine or tyrosine ADP-ribosylation of proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units (PubMed:19764761, PubMed:25043379, PubMed:28190768, PubMed:29954836, PubMed:35393539, PubMed:7852410, PubMed:9315851). Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage (PubMed:33186521, PubMed:34874266). Specificity for the different amino acids is conferred by interacting factors, such as HPF1 and NMNAT1 (PubMed:28190768, PubMed:29954836, PubMed:32028527, PubMed:33186521, PubMed:33589610, PubMed:34625544, PubMed:34874266). Following interaction with HPF1, catalyzes serine ADP-ribosylation of target proteins; HPF1 confers serine specificity by completing the PARP1 active site (PubMed:28190768, PubMed:29954836, PubMed:32028527, PubMed:33186521, PubMed:33589610, PubMed:34625544, PubMed:34874266). Also catalyzes tyrosine ADP-ribosylation of target proteins following interaction with HPF1 (PubMed:29954836, PubMed:30257210). Following interaction with NMNAT1, catalyzes glutamate and aspartate ADP-ribosylation of target proteins; NMNAT1 confers glutamate and aspartate specificity (By similarity). PARP1 initiates the repair of DNA breaks: recognizes and binds DNA breaks within chromatin and recruits HPF1, licensing serine ADP-ribosylation of target proteins, such as histones (H2BS6ADPr and H3S10ADPr), thereby promoting decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks (PubMed:17177976, PubMed:18172500, PubMed:19344625, PubMed:19661379, PubMed:23230272, PubMed:27067600, PubMed:34465625, PubMed:34874266). HPF1 initiates serine ADP-ribosylation but restricts the polymerase activity of PARP1 in order to limit the length of poly-ADP-ribose chains (PubMed:33683197, PubMed:34732825, PubMed:34795260). In addition to base excision repair (BER) pathway, also involved in double-strand breaks (DSBs) repair: together with TIMELESS, accumulates at DNA damage sites and promotes homologous recombination repair by mediating poly-ADP-ribosylation (PubMed:26344098, PubMed:30356214). Mediates the poly-ADP-ribosylation of a number of proteins, including itself, APLF, CHFR, RPA1 and NFAT5 (PubMed:17396150, PubMed:19764761, PubMed:24906880, PubMed:34049076). In addition to proteins, also able to ADP-ribosylate DNA: catalyzes ADP-ribosylation of DNA strand break termini containing terminal phosphates and a 2'-OH group in single- and double-stranded DNA, respectively (PubMed:27471034). Required for PARP9 and DTX3L recruitment to DNA damage sites (PubMed:23230272). PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites (PubMed:23230272). PARP1-mediated DNA repair in neurons plays a role in sleep: senses DNA damage in neurons and promotes sleep, facilitating efficient DNA repair (By similarity). In addition to DNA repair, also involved in other processes, such as transcription regulation, programmed cell death, membrane repair, adipogenesis and innate immunity (PubMed:15607977, PubMed:17177976, PubMed:19344625, PubMed:27256882, PubMed:32315358, PubMed:32844745, PubMed:35124853, PubMed:35393539, PubMed:35460603). Acts as a repressor of transcription: binds to nucleosomes and modulates chromatin structure in a manner similar to histone H1, thereby altering RNA polymerase II (PubMed:15607977, PubMed:22464733). Acts both as a positive and negative regulator of transcription elongation, depending on the context (PubMed:27256882, PubMed:35393539). Acts as a positive regulator of transcription elongation by mediating poly-ADP-ribosylation of NELFE, preventing RNA-binding activity of NELFE and relieving transcription pausing (PubMed:27256882). Acts as a negative regulator of transcription elongation in response to DNA damage by catalyzing poly-ADP-ribosylation of CCNT1, disrupting the phase separation activity of CCNT1 and subsequent activation of CDK9 (PubMed:35393539). Involved in replication fork progression following interaction with CARM1: mediates poly-ADP-ribosylation at replication forks, slowing fork progression (PubMed:33412112). Poly-ADP-ribose chains generated by PARP1 also play a role in poly-ADP-ribose-dependent cell death, a process named parthanatos (By similarity). Also acts as a negative regulator of the cGAS-STING pathway (PubMed:32315358, PubMed:32844745, PubMed:35460603). Acts by mediating poly-ADP-ribosylation of CGAS: PARP1 translocates into the cytosol following phosphorylation by PRKDC and catalyzes poly-ADP-ribosylation and inactivation of CGAS (PubMed:35460603). Acts as a negative regulator of adipogenesis: catalyzes poly-ADP-ribosylation of histone H2B on 'Glu-35' (H2BE35ADPr) following interaction with NMNAT1, inhibiting phosphorylation of H2B at 'Ser-36' (H2BS36ph), thereby blocking expression of pro-adipogenetic genes (By similarity). Involved in the synthesis of ATP in the nucleus, together with NMNAT1, PARG and NUDT5 (PubMed:27257257). Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming (PubMed:27257257).</text>
  </comment>
  <comment type="function">
    <molecule>Poly [ADP-ribose] polymerase 1, processed C-terminus</molecule>
    <text evidence="76">Promotes AIFM1-mediated apoptosis (PubMed:33168626). This form, which translocates into the cytoplasm following cleavage by caspase-3 (CASP3) and caspase-7 (CASP7) in response to apoptosis, is auto-poly-ADP-ribosylated and serves as a poly-ADP-ribose carrier to induce AIFM1-mediated apoptosis (PubMed:33168626).</text>
  </comment>
  <comment type="function">
    <molecule>Poly [ADP-ribose] polymerase 1, processed N-terminus</molecule>
    <text evidence="95">This cleavage form irreversibly binds to DNA breaks and interferes with DNA repair, promoting DNA damage-induced apoptosis.</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="24 28 49 51 59 74 81 102">
      <text>NAD(+) + (ADP-D-ribosyl)n-acceptor = nicotinamide + (ADP-D-ribosyl)n+1-acceptor + H(+).</text>
      <dbReference type="EC" id="2.4.2.30"/>
    </reaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="54 55 71 77 81 84 86 119">
      <text>L-seryl-[protein] + NAD(+) = H(+) + nicotinamide + O-(ADP-D-ribosyl)-L-seryl-[protein]</text>
      <dbReference type="Rhea" id="RHEA:58232"/>
      <dbReference type="Rhea" id="RHEA-COMP:9863"/>
      <dbReference type="Rhea" id="RHEA-COMP:15091"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:17154"/>
      <dbReference type="ChEBI" id="CHEBI:29999"/>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
      <dbReference type="ChEBI" id="CHEBI:142556"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="54 55 71 77 81 84 86 119">
      <dbReference type="Rhea" id="RHEA:58233"/>
    </physiologicalReaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="28 49 99">
      <text>L-aspartyl-[protein] + NAD(+) = 4-O-(ADP-D-ribosyl)-L-aspartyl-[protein] + nicotinamide</text>
      <dbReference type="Rhea" id="RHEA:54424"/>
      <dbReference type="Rhea" id="RHEA-COMP:9867"/>
      <dbReference type="Rhea" id="RHEA-COMP:13832"/>
      <dbReference type="ChEBI" id="CHEBI:17154"/>
      <dbReference type="ChEBI" id="CHEBI:29961"/>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
      <dbReference type="ChEBI" id="CHEBI:138102"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="28 49 99">
      <dbReference type="Rhea" id="RHEA:54425"/>
    </physiologicalReaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="28 49 55">
      <text>L-glutamyl-[protein] + NAD(+) = 5-O-(ADP-D-ribosyl)-L-glutamyl-[protein] + nicotinamide</text>
      <dbReference type="Rhea" id="RHEA:58224"/>
      <dbReference type="Rhea" id="RHEA-COMP:10208"/>
      <dbReference type="Rhea" id="RHEA-COMP:15089"/>
      <dbReference type="ChEBI" id="CHEBI:17154"/>
      <dbReference type="ChEBI" id="CHEBI:29973"/>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
      <dbReference type="ChEBI" id="CHEBI:142540"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="28 49 55">
      <dbReference type="Rhea" id="RHEA:58225"/>
    </physiologicalReaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="119 120">
      <text>L-tyrosyl-[protein] + NAD(+) = H(+) + nicotinamide + O-(ADP-D-ribosyl)-L-tyrosyl-[protein]</text>
      <dbReference type="Rhea" id="RHEA:58236"/>
      <dbReference type="Rhea" id="RHEA-COMP:10136"/>
      <dbReference type="Rhea" id="RHEA-COMP:15092"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:17154"/>
      <dbReference type="ChEBI" id="CHEBI:46858"/>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
      <dbReference type="ChEBI" id="CHEBI:142557"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="119 120">
      <dbReference type="Rhea" id="RHEA:58237"/>
    </physiologicalReaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="98">
      <text>L-histidyl-[protein] + NAD(+) = H(+) + N(tele)-(ADP-D-ribosyl)-L-histidyl-[protein] + nicotinamide</text>
      <dbReference type="Rhea" id="RHEA:72071"/>
      <dbReference type="Rhea" id="RHEA-COMP:9745"/>
      <dbReference type="Rhea" id="RHEA-COMP:18085"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:17154"/>
      <dbReference type="ChEBI" id="CHEBI:29979"/>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
      <dbReference type="ChEBI" id="CHEBI:191398"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="98">
      <dbReference type="Rhea" id="RHEA:72072"/>
    </physiologicalReaction>
  </comment>
  <comment type="activity regulation">
    <text evidence="32 41 52 53 62 72 74 75 78 84 86 93">ADP-ribosyltransferase activity is regulated via an allosteric activation mechanism (PubMed:22582261, PubMed:26626479, PubMed:26626480, PubMed:32241924, PubMed:32358582). In absence of activation signal, PARP1 is autoinhibited by the PARP alpha-helical domain (also named HD region), which prevents effective NAD(+)-binding (PubMed:26626479, PubMed:26626480, PubMed:32241924). Activity is highly stimulated by signals, such as DNA strand breaks (PubMed:20388712, PubMed:32241924, PubMed:32358582). Binding to damaged DNA unfolds the PARP alpha-helical domain, relieving autoinhibition (PubMed:22582261, PubMed:26626479, PubMed:26626480, PubMed:32241924). Poly-ADP-ribosyltransferase activity is tightly regulated and PARP1 is removed from damaged chromatin following initial poly-ADP-ribosylation of chromatin to avoid prolonged residence (trapping) that has cytotoxic consequences (PubMed:34210965, PubMed:34625544, PubMed:35013556). A number of factors (VCP/p97) or post-translational modifications (auto-poly-ADP-ribosylation or ubiquitination) promote PARP1 removal from chromatin (PubMed:34210965, PubMed:34625544, PubMed:35013556). ADP-ribosyltransferase activity is inhibited by a number of PARP inhibitors (PARPi) compounds, that are used the treatment of breast or ovarian cancers that have defects in DNA repair by homologous recombination (PubMed:29487285, PubMed:32241924, PubMed:32358582). PARPi molecules can be classified in three categories: type I compounds (EB-47, UKTT15 and BAD) that promote allosteric retention of PARP1 on DNA, type II inhibitors (talazoparib and olaparib) that mediate a non-allosteric inhibition, and type III inhibitors (rucaparib, niraparib, and veliparib) that promote allosteric release from DNA (PubMed:29487285, PubMed:32241924, PubMed:33361107). Trapping to chromatin by PARPi molecules triggers activation of the cGAS-STING pathway (PubMed:32844745).</text>
  </comment>
  <comment type="biophysicochemical properties">
    <kinetics>
      <KM evidence="102">130 uM for NAD(+)</KM>
      <text evidence="102">kcat is 390 sec(-1) for NAD(+).</text>
    </kinetics>
  </comment>
  <comment type="subunit">
    <text evidence="1 2 14 17 19 21 22 26 27 29 30 34 35 37 42 44 45 46 47 50 51 54 59 61 63 66 68 69 70 71 79 80 83 88 90 93 94 97 100 104">Homodimer; PARP-type zinc-fingers from separate PARP1 molecules form a dimer module that specifically recognizes DNA strand breaks (PubMed:22683995). Heterodimer; heterodimerizes with PARP2 (By similarity). Interacts (via the PARP catalytic domain) with HPF1 (PubMed:27067600, PubMed:28190768, PubMed:29954836, PubMed:32028527, PubMed:33589610). Interacts with NMNAT1 (By similarity). Interacts with nucleosomes; with a preference for nucleosomes containing H2A.X (PubMed:15607977, PubMed:31848352). Interacts with APTX (PubMed:15044383). Component of a base excision repair (BER) complex, containing at least XRCC1, PARP1, PARP2, POLB and LRIG3 (By similarity). Interacts with SRY (PubMed:16904257). The SWAP complex consists of NPM1, NCL, PARP1 and SWAP70 (By similarity). Interacts with TIAM2 (By similarity). Interacts with PARP3; leading to activate PARP1 in absence of DNA (PubMed:20064938). Interacts (when poly-ADP-ribosylated) with CHD1L (via macro domain) (PubMed:19661379, PubMed:29220653). Interacts with the DNA polymerase alpha catalytic subunit POLA1; this interaction functions as part of the control of replication fork progression (PubMed:9518481). Interacts with EEF1A1 and TXK (PubMed:17177976). Interacts with RNF4 (PubMed:19779455). Interacts with RNF146 (PubMed:21799911). Interacts with ZNF423 (PubMed:22863007). Interacts with APLF (PubMed:17396150). Interacts with SNAI1 (via zinc fingers); the interaction requires SNAI1 to be poly-ADP-ribosylated and non-phosphorylated (active) by GSK3B (PubMed:21577210). Interacts (when poly-ADP-ribosylated) with PARP9 (PubMed:23230272). Interacts with NR4A3; activates PARP1 by improving acetylation of PARP1 and suppressing the interaction between PARP1 and SIRT1 (By similarity). Interacts (via catalytic domain) with PUM3; the interaction inhibits the poly-ADP-ribosylation activity of PARP1 and the degradation of PARP1 by CASP3 following genotoxic stress (PubMed:21266351). Interacts with ZNF365 (PubMed:23966166). Interacts with RRP1B (PubMed:19710015). Interacts with TIMELESS; the interaction is direct (PubMed:26344098). Interacts with CGAS; leading to impede the formation of the PARP1-TIMELESS complex (PubMed:30356214). Interacts with KHDC3L, the interaction is increased following the formation of DNA double-strand breaks (PubMed:31609975). Interacts (when auto-poly-ADP-ribosylated) with XRCC1; leading to inhibit PARP1 ADP-ribosyltransferase activity (PubMed:34102106, PubMed:34811483). Interacts with SPINDOC; promoting PARP1 ADP-ribosyltransferase activity (PubMed:34737271). Interacts with BANF1; leading to inhibit PARP1 ADP-ribosyltransferase activity in response to oxidative DNA damage (PubMed:31796734). Interacts (when sumoylated and ubiquitinated) with VCP/p97; leading to its extraction from chromatin (PubMed:35013556). Interacts with YARS1; Interacts with PACMP micropeptide; interaction (PubMed:25533949). Interacts with PACMP micropeptide; Interacts with PACMP micropeptide; interaction (PubMed:35219381). Interacts (when poly-ADP-ribosylated) with isoform 1 of MACROH2A1; MACROH2A1 specifically binds to poly-ADP-ribose chains and inhibits PARP1 activity, limiting the consumption of nuclear NAD(+) (By similarity). Interacts with CARM1; promoting recruitment to replication forks (PubMed:33412112). Interacts with RECQL (PubMed:35025765). Interacts with ZNF32; the interaction reshapes ZNF432 interacting proteins (PubMed:37823600). Interacts with TPRN; TPRN interacts with a number of DNA damage response proteins, is recruited to sites of DNA damage and may play a role in DNA damage repair (PubMed:23213405).</text>
  </comment>
  <comment type="subunit">
    <molecule>Poly [ADP-ribose] polymerase 1, processed C-terminus</molecule>
    <text evidence="76">Interacts (when auto-poly-ADP-ribosylated) with AIFM1.</text>
  </comment>
  <comment type="subunit">
    <text evidence="38">(Microbial infection) Interacts with human herpesvirus 8 (KSHV) protein RTA/ORF50; this interaction negatively regulates RTA/ORF50 transactivation activity.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-1256044">
      <id>Q8IW19</id>
      <label>APLF</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-847814">
      <id>Q7Z2E3</id>
      <label>APTX</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-524064">
      <id>P42574</id>
      <label>CASP3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-1172054">
      <id>P49715</id>
      <label>CEBPA</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-15797018">
      <id>Q86WJ1-1</id>
      <label>CHD1L</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-719459">
      <id>P26358</id>
      <label>DNMT1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-448924">
      <id>Q01094</id>
      <label>E2F1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-399163">
      <id>Q96L91</id>
      <label>EP400</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-79704">
      <id>P11308</id>
      <label>ERG</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>7</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-11173743">
      <id>O60741</id>
      <label>HCN1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-389432">
      <id>P09429</id>
      <label>HMGB1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-3915542">
      <id>Q13007</id>
      <label>IL24</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-5324932">
      <id>Q9BQ69</id>
      <label>MACROD1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-741360">
      <id>P08651</id>
      <label>NFIC</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-8502288">
      <id>Q9Y530</id>
      <label>OARD1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-355676">
      <id>P09874</id>
      <label>PARP1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-473160">
      <id>Q8N2W9</id>
      <label>PIAS4</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-2823728">
      <id>P46063</id>
      <label>RECQL</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-722397">
      <id>Q9NTX7</id>
      <label>RNF146</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-5280110">
      <id>Q14684-1</id>
      <label>RRP1B</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-1045459">
      <id>O95863</id>
      <label>SNAI1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>10</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-80140">
      <id>P63165</id>
      <label>SUMO1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-366083">
      <id>P04637</id>
      <label>TP53</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-3390054">
      <id>P0CG48</id>
      <label>UBC</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-368417">
      <id>Q14191</id>
      <label>WRN</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>8</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-947466">
      <id>P18887</id>
      <label>XRCC1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>7</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-1048893">
      <id>P54577</id>
      <label>YARS1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-950016">
      <id>Q2M1K9</id>
      <label>ZNF423</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-355676">
      <id>P09874</id>
    </interactant>
    <interactant intactId="EBI-6049807">
      <id>Q02085</id>
      <label>Snai1</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="17 42 46 51 58 67 72 74 79 86 89 93">Chromosome</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="21 37 46 99">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="104">Nucleus</location>
      <location evidence="104">Nucleolus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="99">Cytoplasm</location>
      <location evidence="99">Cytosol</location>
    </subcellularLocation>
    <text evidence="17 42 46 51 58 67 72 74 79 86 89 93 99">Localizes to sites of DNA damage (PubMed:22683995, PubMed:23230272, PubMed:26344098, PubMed:27568560, PubMed:30675909, PubMed:32241924, PubMed:32358582, PubMed:34625544, PubMed:34795260). Recognizes (via PARP-type zinc-fingers) and binds DNA strand breaks (PubMed:22683995). Also binds normal/undamaged chromatin (PubMed:15607977). Auto poly-ADP-ribosylation promotes dissociation from chromatin (PubMed:15607977, PubMed:30675909, PubMed:32358582, PubMed:34625544). Extracted from chromatin by VCP/p97 following sumoylation and ubiquitination (PubMed:35013556). Translocates from the nucleus to the cytosol following phosphorylation by PRKDC (PubMed:35460603). Recruited to replication forks following interaction with CARM1 (PubMed:33412112).</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Poly [ADP-ribose] polymerase 1, processed N-terminus</molecule>
    <subcellularLocation>
      <location evidence="76 95 105">Chromosome</location>
    </subcellularLocation>
    <text evidence="76 95 105">Following cleavage by caspase-3 (CASP3) and caspase-7 (CASP7) in response to apoptosis, this cleavage form irreversibly binds to DNA breaks.</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Poly [ADP-ribose] polymerase 1, processed C-terminus</molecule>
    <subcellularLocation>
      <location evidence="76">Cytoplasm</location>
    </subcellularLocation>
    <text evidence="76">Following cleavage by caspase-3 (CASP3) and caspase-7 (CASP7) in response to apoptosis, translocates into the cytoplasm, where the auto-poly-ADP-ribosylated form serves as a poly-ADP-ribose carrier to induce AIFM1-mediated apoptosis.</text>
  </comment>
  <comment type="domain">
    <text evidence="42">The two PARP-type zinc-fingers (also named Zn1 and Zn2) specifically recognize DNA strand breaks: PARP-type zinc-finger 1 binds PARP-type zinc-finger 2 from a separate PARP1 molecule to form a dimeric module that specifically recognizes DNA strand breaks.</text>
  </comment>
  <comment type="domain">
    <text evidence="31">The PADR1-type (also named Zn3) zinc-finger mediates an interdomain contact and is required for the ability of PARP1 to regulate chromatin structure.</text>
  </comment>
  <comment type="domain">
    <text evidence="92">The BRCT domain is able to bind intact DNA without activating the poly-ADP-ribosyltransferase activity (PubMed:34919819). The BRCT domain mediates DNA intrastrand transfer (named 'monkey-bar mechanism') that allows rapid movements of PARP1 through the nucleus (PubMed:34919819).</text>
  </comment>
  <comment type="domain">
    <text evidence="3">The WGR domain bridges two nucleosomes, with the broken DNA aligned in a position suitable for ligation. The bridging induces structural changes in PARP1 that signal the recognition of a DNA break to the catalytic domain of PARP1, promoting HPF1 recruitment and subsequent activation of PARP1, licensing serine ADP-ribosylation of target proteins.</text>
  </comment>
  <comment type="domain">
    <text evidence="52 53">The PARP alpha-helical domain (also named HD region) prevents effective NAD(+)-binding in absence of activation signal (PubMed:26626479, PubMed:26626480). Binding to damaged DNA unfolds the PARP alpha-helical domain, relieving autoinhibition (PubMed:26626479, PubMed:26626480).</text>
  </comment>
  <comment type="PTM">
    <text evidence="17 26 28 32 36 41 43 58 59 67 74 84 86">Poly-ADP-ribosylated on serine, glutamate and aspartate residues by autocatalysis (PubMed:19764761, PubMed:20388712, PubMed:22582261). Auto-ADP-ribosylation on serine takes place following interaction with HPF1 (PubMed:28190768, PubMed:34625544). Auto poly-ADP-ribosylation on serine residues promotes its dissociation from chromatin (PubMed:15607977, PubMed:30675909, PubMed:32358582, PubMed:34210965, PubMed:34625544). Poly-ADP-ribosylated by PARP2; poly-ADP-ribosylation mediates the recruitment of CHD1L to DNA damage sites (PubMed:19661379). Mono-ADP-ribosylated at Lys-521 by SIRT6 in response to oxidative stress, promoting recruitment to double-strand breaks (DSBs) sites (PubMed:21680843, PubMed:22753495, PubMed:27568560).</text>
  </comment>
  <comment type="PTM">
    <text evidence="12 21 99">Phosphorylated at Thr-594 by PRKDC in response to DNA damage following virus infection, promoting its translocation to the cytosol (PubMed:10467406, PubMed:35460603). Phosphorylated by TXK (PubMed:17177976).</text>
  </comment>
  <comment type="PTM">
    <text evidence="1">S-nitrosylated, leading to inhibit transcription regulation activity.</text>
  </comment>
  <comment type="PTM">
    <text evidence="13 18 39 40 76 95 101">Proteolytically cleaved by caspase-3 (CASP3) and caspase-7 (CASP7) in response to apoptosis to generate the Poly [ADP-ribose] polymerase 1, processed N-terminus and Poly [ADP-ribose] polymerase 1, processed C-terminus forms (PubMed:10497198, PubMed:16374543, PubMed:22451931, PubMed:22464733, PubMed:33168626, PubMed:35104452, PubMed:7596430). CASP3-mediated cleavage is promoted by the TP53/p53-induced long non-coding RNA SPARCLE, which binds PARP1 in response to genotoxic stress (PubMed:35104452).</text>
  </comment>
  <comment type="PTM">
    <text evidence="93">Sumoylated with SUMO1 or SUMO2 by PIAS4 following prolonged residence (trapping) to chromatin (PubMed:35013556). Sumoylation promotes ubiquitination by RNF4 and removal from chromatin by VCP/p97 (PubMed:35013556).</text>
  </comment>
  <comment type="PTM">
    <text evidence="93">Ubiquitinated by RNF4 following sumoylation by PIAS4 in response to prolonged residence (trapping) to chromatin (PubMed:35013556). Ubiquitination promotes removal from chromatin by VCP/p97 (PubMed:35013556).</text>
  </comment>
  <comment type="similarity">
    <text evidence="10 118">Belongs to the ARTD/PARP family.</text>
  </comment>
  <comment type="online information" name="Protein Spotlight">
    <link uri="https://web.expasy.org/spotlight/back_issues/235/"/>
    <text>Catalysis - Issue 235 of April 2021</text>
  </comment>
  <dbReference type="EC" id="2.4.2.30" evidence="24 28 49 51 59 81 102"/>
  <dbReference type="EC" id="2.4.2.-" evidence="57 28 49 55 81 84 86 98"/>
  <dbReference type="EMBL" id="M18112">
    <property type="protein sequence ID" value="AAA60137.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="J03473">
    <property type="protein sequence ID" value="AAB59447.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M32721">
    <property type="protein sequence ID" value="AAA60155.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29786">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29545">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29766">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29767">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29768">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29769">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29770">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29771">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29772">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29773">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29774">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29775">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29776">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29777">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29778">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29779">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29780">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29781">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29783">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29784">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29785">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29544">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M29782">
    <property type="protein sequence ID" value="AAA51663.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AF524947">
    <property type="protein sequence ID" value="AAM75364.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL359704">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL359742">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471098">
    <property type="protein sequence ID" value="EAW69783.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC037545">
    <property type="protein sequence ID" value="AAH37545.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X56140">
    <property type="protein sequence ID" value="CAA39606.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X56141">
    <property type="protein sequence ID" value="CAA39606.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X16674">
    <property type="protein sequence ID" value="CAA34663.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M60436">
    <property type="protein sequence ID" value="AAA60000.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M17081">
    <property type="protein sequence ID" value="AAA51599.1"/>
    <property type="status" value="ALT_SEQ"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS1554.1"/>
  <dbReference type="PIR" id="A29725">
    <property type="entry name" value="A29725"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001609.2">
    <property type="nucleotide sequence ID" value="NM_001618.3"/>
  </dbReference>
  <dbReference type="PDB" id="1UK0">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="1UK1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="1WOK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="2COK">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=387-486"/>
  </dbReference>
  <dbReference type="PDB" id="2CR9">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=518-643"/>
  </dbReference>
  <dbReference type="PDB" id="2CS2">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=103-223"/>
  </dbReference>
  <dbReference type="PDB" id="2DMJ">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=1-93"/>
  </dbReference>
  <dbReference type="PDB" id="2JVN">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=233-358"/>
  </dbReference>
  <dbReference type="PDB" id="2L30">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=1-108"/>
  </dbReference>
  <dbReference type="PDB" id="2L31">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=103-214"/>
  </dbReference>
  <dbReference type="PDB" id="2N8A">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=1-214"/>
  </dbReference>
  <dbReference type="PDB" id="2RCW">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="2RD6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="2RIQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.70 A"/>
    <property type="chains" value="A=216-366"/>
  </dbReference>
  <dbReference type="PDB" id="3GJW">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="3GN7">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="3L3L">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="3L3M">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="3OD8">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.40 A"/>
    <property type="chains" value="A/B/C/D/E/F/G/H=2-96"/>
  </dbReference>
  <dbReference type="PDB" id="3ODA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.64 A"/>
    <property type="chains" value="A/B/C/D/E/F/G/H=2-96"/>
  </dbReference>
  <dbReference type="PDB" id="3ODC">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A/B=105-206"/>
  </dbReference>
  <dbReference type="PDB" id="3ODE">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.95 A"/>
    <property type="chains" value="A/B=105-206"/>
  </dbReference>
  <dbReference type="PDB" id="4AV1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="A/B/C/D=5-202"/>
  </dbReference>
  <dbReference type="PDB" id="4DQY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.25 A"/>
    <property type="chains" value="A/D=1-96, B/E=216-366, C/F=518-1014"/>
  </dbReference>
  <dbReference type="PDB" id="4GV7">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.89 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4HHY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.36 A"/>
    <property type="chains" value="A/B/C/D=660-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4HHZ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.72 A"/>
    <property type="chains" value="A/B/C/D=660-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4L6S">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4OPX">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.31 A"/>
    <property type="chains" value="A/D=1-97, A/D=207-366, C/F=518-1014"/>
  </dbReference>
  <dbReference type="PDB" id="4OQA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.65 A"/>
    <property type="chains" value="A/D=1-97, A/D=207-366, C/F=518-1014"/>
  </dbReference>
  <dbReference type="PDB" id="4OQB">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.36 A"/>
    <property type="chains" value="A/D=1-97, A/D=207-366, C/F=518-1014"/>
  </dbReference>
  <dbReference type="PDB" id="4PJT">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.35 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4R5W">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.84 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4R6E">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4RV6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.19 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4UND">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4UXB">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.22 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="4XHU">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.09 A"/>
    <property type="chains" value="A/C=661-1014"/>
  </dbReference>
  <dbReference type="PDB" id="4ZZZ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.90 A"/>
    <property type="chains" value="A/B=655-1014"/>
  </dbReference>
  <dbReference type="PDB" id="5A00">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.75 A"/>
    <property type="chains" value="A=655-1014"/>
  </dbReference>
  <dbReference type="PDB" id="5DS3">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.60 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="5HA9">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="4.01 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5KPN">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5KPO">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.65 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5KPP">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.33 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5KPQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.55 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5WRQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.65 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5WRY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5WRZ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5WS0">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.60 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5WS1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.90 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5WTC">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5XSR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="5XST">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A=662-1010"/>
  </dbReference>
  <dbReference type="PDB" id="5XSU">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.40 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="6BHV">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A/B/C/D=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="6GHK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.28 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="6M3I">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.98 A"/>
    <property type="chains" value="B=788-1014"/>
  </dbReference>
  <dbReference type="PDB" id="6NRF">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="6NRG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.70 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="6NRH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.50 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="6NRI">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="6NRJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.65 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="6NTU">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.80 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="6VKK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A/B/C/D=661-1011"/>
  </dbReference>
  <dbReference type="PDB" id="6VKO">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A/B/C/D=661-1011"/>
  </dbReference>
  <dbReference type="PDB" id="6VKQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="A/B/C/D=661-1011"/>
  </dbReference>
  <dbReference type="PDB" id="6XVW">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A/B=663-1014"/>
  </dbReference>
  <dbReference type="PDB" id="7AAA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.74 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7AAB">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7AAC">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.59 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7AAD">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.21 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7CMW">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7KK2">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.70 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7KK3">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.06 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7KK4">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.96 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7KK5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.70 A"/>
    <property type="chains" value="A/B/C/D=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7KK6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.06 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7ONR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.05 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7ONS">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.97 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7ONT">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.85 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="7S68">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.30 A"/>
    <property type="chains" value="A=1-366, B=527-786"/>
  </dbReference>
  <dbReference type="PDB" id="7S6H">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="A/C=1-366, B/D=518-1014"/>
  </dbReference>
  <dbReference type="PDB" id="7S6M">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.20 A"/>
    <property type="chains" value="A/C=1-366, B/D=518-1014"/>
  </dbReference>
  <dbReference type="PDB" id="7S81">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.60 A"/>
    <property type="chains" value="A/F/I/N=1-96, B/G/J/O=216-366, C/H/K/P=527-786"/>
  </dbReference>
  <dbReference type="PDB" id="7SCY">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.10 A"/>
    <property type="chains" value="K=385-492"/>
  </dbReference>
  <dbReference type="PDB" id="7SCZ">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.50 A"/>
    <property type="chains" value="K=385-492"/>
  </dbReference>
  <dbReference type="PDB" id="8FYY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="8FYZ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.40 A"/>
    <property type="chains" value="A/B=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="8FZ1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="A/B=788-1012"/>
  </dbReference>
  <dbReference type="PDB" id="8G0H">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.80 A"/>
    <property type="chains" value="A/C=1-366, B/D=518-1014"/>
  </dbReference>
  <dbReference type="PDB" id="8HE7">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="8HLR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.85 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="8JNZ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.84 A"/>
    <property type="chains" value="A/B=662-1011"/>
  </dbReference>
  <dbReference type="PDB" id="8U4W">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.02 A"/>
    <property type="chains" value="A/B/C/D=788-1011"/>
  </dbReference>
  <dbReference type="PDBsum" id="1UK0"/>
  <dbReference type="PDBsum" id="1UK1"/>
  <dbReference type="PDBsum" id="1WOK"/>
  <dbReference type="PDBsum" id="2COK"/>
  <dbReference type="PDBsum" id="2CR9"/>
  <dbReference type="PDBsum" id="2CS2"/>
  <dbReference type="PDBsum" id="2DMJ"/>
  <dbReference type="PDBsum" id="2JVN"/>
  <dbReference type="PDBsum" id="2L30"/>
  <dbReference type="PDBsum" id="2L31"/>
  <dbReference type="PDBsum" id="2N8A"/>
  <dbReference type="PDBsum" id="2RCW"/>
  <dbReference type="PDBsum" id="2RD6"/>
  <dbReference type="PDBsum" id="2RIQ"/>
  <dbReference type="PDBsum" id="3GJW"/>
  <dbReference type="PDBsum" id="3GN7"/>
  <dbReference type="PDBsum" id="3L3L"/>
  <dbReference type="PDBsum" id="3L3M"/>
  <dbReference type="PDBsum" id="3OD8"/>
  <dbReference type="PDBsum" id="3ODA"/>
  <dbReference type="PDBsum" id="3ODC"/>
  <dbReference type="PDBsum" id="3ODE"/>
  <dbReference type="PDBsum" id="4AV1"/>
  <dbReference type="PDBsum" id="4DQY"/>
  <dbReference type="PDBsum" id="4GV7"/>
  <dbReference type="PDBsum" id="4HHY"/>
  <dbReference type="PDBsum" id="4HHZ"/>
  <dbReference type="PDBsum" id="4L6S"/>
  <dbReference type="PDBsum" id="4OPX"/>
  <dbReference type="PDBsum" id="4OQA"/>
  <dbReference type="PDBsum" id="4OQB"/>
  <dbReference type="PDBsum" id="4PJT"/>
  <dbReference type="PDBsum" id="4R5W"/>
  <dbReference type="PDBsum" id="4R6E"/>
  <dbReference type="PDBsum" id="4RV6"/>
  <dbReference type="PDBsum" id="4UND"/>
  <dbReference type="PDBsum" id="4UXB"/>
  <dbReference type="PDBsum" id="4XHU"/>
  <dbReference type="PDBsum" id="4ZZZ"/>
  <dbReference type="PDBsum" id="5A00"/>
  <dbReference type="PDBsum" id="5DS3"/>
  <dbReference type="PDBsum" id="5HA9"/>
  <dbReference type="PDBsum" id="5KPN"/>
  <dbReference type="PDBsum" id="5KPO"/>
  <dbReference type="PDBsum" id="5KPP"/>
  <dbReference type="PDBsum" id="5KPQ"/>
  <dbReference type="PDBsum" id="5WRQ"/>
  <dbReference type="PDBsum" id="5WRY"/>
  <dbReference type="PDBsum" id="5WRZ"/>
  <dbReference type="PDBsum" id="5WS0"/>
  <dbReference type="PDBsum" id="5WS1"/>
  <dbReference type="PDBsum" id="5WTC"/>
  <dbReference type="PDBsum" id="5XSR"/>
  <dbReference type="PDBsum" id="5XST"/>
  <dbReference type="PDBsum" id="5XSU"/>
  <dbReference type="PDBsum" id="6BHV"/>
  <dbReference type="PDBsum" id="6GHK"/>
  <dbReference type="PDBsum" id="6M3I"/>
  <dbReference type="PDBsum" id="6NRF"/>
  <dbReference type="PDBsum" id="6NRG"/>
  <dbReference type="PDBsum" id="6NRH"/>
  <dbReference type="PDBsum" id="6NRI"/>
  <dbReference type="PDBsum" id="6NRJ"/>
  <dbReference type="PDBsum" id="6NTU"/>
  <dbReference type="PDBsum" id="6VKK"/>
  <dbReference type="PDBsum" id="6VKO"/>
  <dbReference type="PDBsum" id="6VKQ"/>
  <dbReference type="PDBsum" id="6XVW"/>
  <dbReference type="PDBsum" id="7AAA"/>
  <dbReference type="PDBsum" id="7AAB"/>
  <dbReference type="PDBsum" id="7AAC"/>
  <dbReference type="PDBsum" id="7AAD"/>
  <dbReference type="PDBsum" id="7CMW"/>
  <dbReference type="PDBsum" id="7KK2"/>
  <dbReference type="PDBsum" id="7KK3"/>
  <dbReference type="PDBsum" id="7KK4"/>
  <dbReference type="PDBsum" id="7KK5"/>
  <dbReference type="PDBsum" id="7KK6"/>
  <dbReference type="PDBsum" id="7ONR"/>
  <dbReference type="PDBsum" id="7ONS"/>
  <dbReference type="PDBsum" id="7ONT"/>
  <dbReference type="PDBsum" id="7S68"/>
  <dbReference type="PDBsum" id="7S6H"/>
  <dbReference type="PDBsum" id="7S6M"/>
  <dbReference type="PDBsum" id="7S81"/>
  <dbReference type="PDBsum" id="7SCY"/>
  <dbReference type="PDBsum" id="7SCZ"/>
  <dbReference type="PDBsum" id="8FYY"/>
  <dbReference type="PDBsum" id="8FYZ"/>
  <dbReference type="PDBsum" id="8FZ1"/>
  <dbReference type="PDBsum" id="8G0H"/>
  <dbReference type="PDBsum" id="8HE7"/>
  <dbReference type="PDBsum" id="8HLR"/>
  <dbReference type="PDBsum" id="8JNZ"/>
  <dbReference type="PDBsum" id="8U4W"/>
  <dbReference type="AlphaFoldDB" id="P09874"/>
  <dbReference type="BMRB" id="P09874"/>
  <dbReference type="EMDB" id="EMD-25042"/>
  <dbReference type="EMDB" id="EMD-25043"/>
  <dbReference type="SMR" id="P09874"/>
  <dbReference type="BioGRID" id="106652">
    <property type="interactions" value="1328"/>
  </dbReference>
  <dbReference type="CORUM" id="P09874"/>
  <dbReference type="DIP" id="DIP-38N"/>
  <dbReference type="ELM" id="P09874"/>
  <dbReference type="IntAct" id="P09874">
    <property type="interactions" value="345"/>
  </dbReference>
  <dbReference type="MINT" id="P09874"/>
  <dbReference type="STRING" id="9606.ENSP00000355759"/>
  <dbReference type="BindingDB" id="P09874"/>
  <dbReference type="ChEMBL" id="CHEMBL3105"/>
  <dbReference type="DrugBank" id="DB04010">
    <property type="generic name" value="2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB03509">
    <property type="generic name" value="2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB03072">
    <property type="generic name" value="2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB03722">
    <property type="generic name" value="3,4-Dihydro-5-Methyl-Isoquinolinone"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB03073">
    <property type="generic name" value="3-Methoxybenzamide"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB07787">
    <property type="generic name" value="5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB07096">
    <property type="generic name" value="6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB07330">
    <property type="generic name" value="A-620223"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB02498">
    <property type="generic name" value="Carba-nicotinamide-adenine-dinucleotide"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB13877">
    <property type="generic name" value="Iniparib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB02701">
    <property type="generic name" value="Nicotinamide"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB11793">
    <property type="generic name" value="Niraparib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB02690">
    <property type="generic name" value="NU1025"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB09074">
    <property type="generic name" value="Olaparib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB12332">
    <property type="generic name" value="Rucaparib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB11760">
    <property type="generic name" value="Talazoparib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB00277">
    <property type="generic name" value="Theophylline"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB07232">
    <property type="generic name" value="Veliparib"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB01593">
    <property type="generic name" value="Zinc"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB14487">
    <property type="generic name" value="Zinc acetate"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB14533">
    <property type="generic name" value="Zinc chloride"/>
  </dbReference>
  <dbReference type="DrugBank" id="DB14548">
    <property type="generic name" value="Zinc sulfate, unspecified form"/>
  </dbReference>
  <dbReference type="DrugCentral" id="P09874"/>
  <dbReference type="GuidetoPHARMACOLOGY" id="2771"/>
  <dbReference type="MoonProt" id="P09874"/>
  <dbReference type="GlyGen" id="P09874">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="P09874"/>
  <dbReference type="MetOSite" id="P09874"/>
  <dbReference type="PhosphoSitePlus" id="P09874"/>
  <dbReference type="SwissPalm" id="P09874"/>
  <dbReference type="BioMuta" id="PARP1"/>
  <dbReference type="DMDM" id="130781"/>
  <dbReference type="CPTAC" id="CPTAC-3240"/>
  <dbReference type="CPTAC" id="CPTAC-3241"/>
  <dbReference type="CPTAC" id="CPTAC-556"/>
  <dbReference type="CPTAC" id="CPTAC-557"/>
  <dbReference type="CPTAC" id="CPTAC-5899"/>
  <dbReference type="jPOST" id="P09874"/>
  <dbReference type="MassIVE" id="P09874"/>
  <dbReference type="PaxDb" id="9606-ENSP00000355759"/>
  <dbReference type="PeptideAtlas" id="P09874"/>
  <dbReference type="ProteomicsDB" id="52271"/>
  <dbReference type="Pumba" id="P09874"/>
  <dbReference type="Antibodypedia" id="3545">
    <property type="antibodies" value="2179 antibodies from 50 providers"/>
  </dbReference>
  <dbReference type="CPTC" id="P09874">
    <property type="antibodies" value="1 antibody"/>
  </dbReference>
  <dbReference type="DNASU" id="142"/>
  <dbReference type="Ensembl" id="ENST00000366794.10">
    <property type="protein sequence ID" value="ENSP00000355759.5"/>
    <property type="gene ID" value="ENSG00000143799.14"/>
  </dbReference>
  <dbReference type="GeneID" id="142"/>
  <dbReference type="KEGG" id="hsa:142"/>
  <dbReference type="MANE-Select" id="ENST00000366794.10">
    <property type="protein sequence ID" value="ENSP00000355759.5"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_001618.4"/>
    <property type="RefSeq protein sequence ID" value="NP_001609.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001hqd.5">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:270"/>
  <dbReference type="CTD" id="142"/>
  <dbReference type="DisGeNET" id="142"/>
  <dbReference type="GeneCards" id="PARP1"/>
  <dbReference type="HGNC" id="HGNC:270">
    <property type="gene designation" value="PARP1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000143799">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="173870">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_P09874"/>
  <dbReference type="OpenTargets" id="ENSG00000143799"/>
  <dbReference type="PharmGKB" id="PA32"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000143799"/>
  <dbReference type="eggNOG" id="KOG1037">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000156058"/>
  <dbReference type="HOGENOM" id="CLU_004841_0_0_1"/>
  <dbReference type="InParanoid" id="P09874"/>
  <dbReference type="OMA" id="MNFKYKY"/>
  <dbReference type="OrthoDB" id="5481368at2759"/>
  <dbReference type="PhylomeDB" id="P09874"/>
  <dbReference type="TreeFam" id="TF316616"/>
  <dbReference type="BRENDA" id="2.4.2.30">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="P09874"/>
  <dbReference type="Reactome" id="R-HSA-110362">
    <property type="pathway name" value="POLB-Dependent Long Patch Base Excision Repair"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-192814">
    <property type="pathway name" value="vRNA Synthesis"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-2173795">
    <property type="pathway name" value="Downregulation of SMAD2/3:SMAD4 transcriptional activity"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-3108214">
    <property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5685939">
    <property type="pathway name" value="HDR through MMEJ (alt-NHEJ)"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5696394">
    <property type="pathway name" value="DNA Damage Recognition in GG-NER"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5696395">
    <property type="pathway name" value="Formation of Incision Complex in GG-NER"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5696400">
    <property type="pathway name" value="Dual Incision in GG-NER"/>
  </dbReference>
  <dbReference type="SignaLink" id="P09874"/>
  <dbReference type="SIGNOR" id="P09874"/>
  <dbReference type="BioGRID-ORCS" id="142">
    <property type="hits" value="41 hits in 1169 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="PARP1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="P09874"/>
  <dbReference type="GeneWiki" id="PARP1"/>
  <dbReference type="GenomeRNAi" id="142"/>
  <dbReference type="Pharos" id="P09874">
    <property type="development level" value="Tclin"/>
  </dbReference>
  <dbReference type="PRO" id="PR:P09874"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 1"/>
  </dbReference>
  <dbReference type="RNAct" id="P09874">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000143799">
    <property type="expression patterns" value="Expressed in ventricular zone and 212 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="P09874">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000785">
    <property type="term" value="C:chromatin"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000781">
    <property type="term" value="C:chromosome, telomeric region"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005739">
    <property type="term" value="C:mitochondrion"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016604">
    <property type="term" value="C:nuclear body"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005635">
    <property type="term" value="C:nuclear envelope"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043596">
    <property type="term" value="C:nuclear replication fork"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005730">
    <property type="term" value="C:nucleolus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032991">
    <property type="term" value="C:protein-containing complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="CAFA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032993">
    <property type="term" value="C:protein-DNA complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="CAFA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0090734">
    <property type="term" value="C:site of DNA damage"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035861">
    <property type="term" value="C:site of double-strand break"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005667">
    <property type="term" value="C:transcription regulator complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003682">
    <property type="term" value="F:chromatin binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003684">
    <property type="term" value="F:damaged DNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003677">
    <property type="term" value="F:DNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0019899">
    <property type="term" value="F:enzyme binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042826">
    <property type="term" value="F:histone deacetylase binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042802">
    <property type="term" value="F:identical protein binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="IntAct"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051287">
    <property type="term" value="F:NAD binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140294">
    <property type="term" value="F:NAD DNA ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003950">
    <property type="term" value="F:NAD+ ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140806">
    <property type="term" value="F:NAD+- protein-aspartate ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140822">
    <property type="term" value="F:NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140816">
    <property type="term" value="F:NAD+-histone H2BS6 serine ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140817">
    <property type="term" value="F:NAD+-histone H3S10 serine ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990404">
    <property type="term" value="F:NAD+-protein ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140807">
    <property type="term" value="F:NAD+-protein-glutamate ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140815">
    <property type="term" value="F:NAD+-protein-histidine ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140805">
    <property type="term" value="F:NAD+-protein-serine ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140808">
    <property type="term" value="F:NAD+-protein-tyrosine ADP-ribosyltransferase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030331">
    <property type="term" value="F:nuclear estrogen receptor binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031491">
    <property type="term" value="F:nucleosome binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016779">
    <property type="term" value="F:nucleotidyltransferase activity"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042803">
    <property type="term" value="F:protein homodimerization activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0019901">
    <property type="term" value="F:protein kinase binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070412">
    <property type="term" value="F:R-SMAD binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0061629">
    <property type="term" value="F:RNA polymerase II-specific DNA-binding transcription factor binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140537">
    <property type="term" value="F:transcription regulator activator activity"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031625">
    <property type="term" value="F:ubiquitin protein ligase binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008270">
    <property type="term" value="F:zinc ion binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006915">
    <property type="term" value="P:apoptotic process"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990966">
    <property type="term" value="P:ATP generation from poly-ADP-D-ribose"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016051">
    <property type="term" value="P:carbohydrate biosynthetic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904646">
    <property type="term" value="P:cellular response to amyloid-beta"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032869">
    <property type="term" value="P:cellular response to insulin stimulus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990090">
    <property type="term" value="P:cellular response to nerve growth factor stimulus"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034599">
    <property type="term" value="P:cellular response to oxidative stress"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034644">
    <property type="term" value="P:cellular response to UV"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071294">
    <property type="term" value="P:cellular response to zinc ion"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0046697">
    <property type="term" value="P:decidualization"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030592">
    <property type="term" value="P:DNA ADP-ribosylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006974">
    <property type="term" value="P:DNA damage response"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006281">
    <property type="term" value="P:DNA repair"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006302">
    <property type="term" value="P:double-strand break repair"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030225">
    <property type="term" value="P:macrophage differentiation"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032042">
    <property type="term" value="P:mitochondrial DNA metabolic process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043504">
    <property type="term" value="P:mitochondrial DNA repair"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007005">
    <property type="term" value="P:mitochondrion organization"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904178">
    <property type="term" value="P:negative regulation of adipose tissue development"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:2001170">
    <property type="term" value="P:negative regulation of ATP biosynthetic process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ParkinsonsUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0160049">
    <property type="term" value="P:negative regulation of cGAS/STING signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045892">
    <property type="term" value="P:negative regulation of DNA-templated transcription"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045824">
    <property type="term" value="P:negative regulation of innate immune response"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904357">
    <property type="term" value="P:negative regulation of telomere maintenance via telomere lengthening"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000122">
    <property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034244">
    <property type="term" value="P:negative regulation of transcription elongation by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043123">
    <property type="term" value="P:positive regulation of canonical NF-kappaB signal transduction"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010613">
    <property type="term" value="P:positive regulation of cardiac muscle hypertrophy"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032786">
    <property type="term" value="P:positive regulation of DNA-templated transcription, elongation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:1905168">
    <property type="term" value="P:positive regulation of double-strand break repair via homologous recombination"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0033148">
    <property type="term" value="P:positive regulation of intracellular estrogen receptor signaling pathway"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051901">
    <property type="term" value="P:positive regulation of mitochondrial depolarization"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904762">
    <property type="term" value="P:positive regulation of myofibroblast differentiation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060545">
    <property type="term" value="P:positive regulation of necroptotic process"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1900182">
    <property type="term" value="P:positive regulation of protein localization to nucleus"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:1903518">
    <property type="term" value="P:positive regulation of single strand break repair"/>
    <property type="evidence" value="ECO:0000316"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060391">
    <property type="term" value="P:positive regulation of SMAD protein signal transduction"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045944">
    <property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="NTNU_SB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070213">
    <property type="term" value="P:protein auto-ADP-ribosylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016540">
    <property type="term" value="P:protein autoprocessing"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071168">
    <property type="term" value="P:protein localization to chromatin"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0036211">
    <property type="term" value="P:protein modification process"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070212">
    <property type="term" value="P:protein poly-ADP-ribosylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1905051">
    <property type="term" value="P:regulation of base-excision repair"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050790">
    <property type="term" value="P:regulation of catalytic activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045188">
    <property type="term" value="P:regulation of circadian sleep/wake cycle, non-REM sleep"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1903376">
    <property type="term" value="P:regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032880">
    <property type="term" value="P:regulation of protein localization"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071932">
    <property type="term" value="P:replication fork reversal"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904044">
    <property type="term" value="P:response to aldosterone"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010332">
    <property type="term" value="P:response to gamma radiation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0023019">
    <property type="term" value="P:signal transduction involved in regulation of gene expression"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000723">
    <property type="term" value="P:telomere maintenance"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006366">
    <property type="term" value="P:transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007179">
    <property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="CDD" id="cd17747">
    <property type="entry name" value="BRCT_PARP1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd01437">
    <property type="entry name" value="parp_like"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd08001">
    <property type="entry name" value="WGR_PARP1_like"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="1.10.20.130">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="2.20.25.630">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.90.228.10">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.40.50.10190">
    <property type="entry name" value="BRCT domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="1.20.142.10">
    <property type="entry name" value="Poly(ADP-ribose) polymerase, regulatory domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.1740.10">
    <property type="entry name" value="Zinc finger, PARP-type"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR050800">
    <property type="entry name" value="ARTD/PARP"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR001357">
    <property type="entry name" value="BRCT_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036420">
    <property type="entry name" value="BRCT_dom_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR038650">
    <property type="entry name" value="PADR1_C_dom_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR008288">
    <property type="entry name" value="PARP"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR049296">
    <property type="entry name" value="PARP1-like_PADR1_N"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012982">
    <property type="entry name" value="PARP1-like_PADR1_Zn_ribbon"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012317">
    <property type="entry name" value="Poly(ADP-ribose)pol_cat_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR004102">
    <property type="entry name" value="Poly(ADP-ribose)pol_reg_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036616">
    <property type="entry name" value="Poly(ADP-ribose)pol_reg_dom_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036930">
    <property type="entry name" value="WGR_dom_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR008893">
    <property type="entry name" value="WGR_domain"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR001510">
    <property type="entry name" value="Znf_PARP"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036957">
    <property type="entry name" value="Znf_PARP_sf"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10459">
    <property type="entry name" value="DNA LIGASE"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10459:SF112">
    <property type="entry name" value="POLY [ADP-RIBOSE] POLYMERASE 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00533">
    <property type="entry name" value="BRCT"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF21728">
    <property type="entry name" value="PADR1_N"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF08063">
    <property type="entry name" value="PADR1_Zn_ribbon"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00644">
    <property type="entry name" value="PARP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02877">
    <property type="entry name" value="PARP_reg"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF05406">
    <property type="entry name" value="WGR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00645">
    <property type="entry name" value="zf-PARP"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PIRSF" id="PIRSF000489">
    <property type="entry name" value="NAD_ADPRT"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00292">
    <property type="entry name" value="BRCT"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM01335">
    <property type="entry name" value="PADR1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00773">
    <property type="entry name" value="WGR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM01336">
    <property type="entry name" value="zf-PARP"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF56399">
    <property type="entry name" value="ADP-ribosylation"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF52113">
    <property type="entry name" value="BRCT domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF47587">
    <property type="entry name" value="Domain of poly(ADP-ribose) polymerase"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF57716">
    <property type="entry name" value="Glucocorticoid receptor-like (DNA-binding domain)"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF142921">
    <property type="entry name" value="WGR domain-like"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50172">
    <property type="entry name" value="BRCT"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS52007">
    <property type="entry name" value="PADR1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51060">
    <property type="entry name" value="PARP_ALPHA_HD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51059">
    <property type="entry name" value="PARP_CATALYTIC"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51977">
    <property type="entry name" value="WGR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00347">
    <property type="entry name" value="ZF_PARP_1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50064">
    <property type="entry name" value="ZF_PARP_2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0013">ADP-ribosylation</keyword>
  <keyword id="KW-0021">Allosteric enzyme</keyword>
  <keyword id="KW-0053">Apoptosis</keyword>
  <keyword id="KW-0158">Chromosome</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0227">DNA damage</keyword>
  <keyword id="KW-0234">DNA repair</keyword>
  <keyword id="KW-0238">DNA-binding</keyword>
  <keyword id="KW-0328">Glycosyltransferase</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0399">Innate immunity</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0479">Metal-binding</keyword>
  <keyword id="KW-0520">NAD</keyword>
  <keyword id="KW-0548">Nucleotidyltransferase</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0804">Transcription</keyword>
  <keyword id="KW-0805">Transcription regulation</keyword>
  <keyword id="KW-0808">Transferase</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <keyword id="KW-0862">Zinc</keyword>
  <keyword id="KW-0863">Zinc-finger</keyword>
  <feature type="initiator methionine" description="Removed" evidence="106 158">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000211320" description="Poly [ADP-ribose] polymerase 1">
    <location>
      <begin position="2"/>
      <end position="1014"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000456361" description="Poly [ADP-ribose] polymerase 1, processed N-terminus" evidence="122">
    <location>
      <begin position="2"/>
      <end position="214"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000456362" description="Poly [ADP-ribose] polymerase 1, processed C-terminus" evidence="122">
    <location>
      <begin position="215"/>
      <end position="1014"/>
    </location>
  </feature>
  <feature type="domain" description="PADR1 zinc-binding" evidence="10">
    <location>
      <begin position="225"/>
      <end position="359"/>
    </location>
  </feature>
  <feature type="domain" description="BRCT" evidence="5">
    <location>
      <begin position="385"/>
      <end position="476"/>
    </location>
  </feature>
  <feature type="domain" description="WGR" evidence="9">
    <location>
      <begin position="542"/>
      <end position="638"/>
    </location>
  </feature>
  <feature type="domain" description="PARP alpha-helical" evidence="8">
    <location>
      <begin position="662"/>
      <end position="779"/>
    </location>
  </feature>
  <feature type="domain" description="PARP catalytic" evidence="7">
    <location>
      <begin position="788"/>
      <end position="1014"/>
    </location>
  </feature>
  <feature type="zinc finger region" description="PARP-type 1" evidence="6">
    <location>
      <begin position="9"/>
      <end position="93"/>
    </location>
  </feature>
  <feature type="zinc finger region" description="PARP-type 2" evidence="6">
    <location>
      <begin position="113"/>
      <end position="203"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="11">
    <location>
      <begin position="198"/>
      <end position="233"/>
    </location>
  </feature>
  <feature type="region of interest" description="Zinc ribbon" evidence="10">
    <location>
      <begin position="290"/>
      <end position="332"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="11">
    <location>
      <begin position="361"/>
      <end position="385"/>
    </location>
  </feature>
  <feature type="region of interest" description="Automodification domain" evidence="109">
    <location>
      <begin position="373"/>
      <end position="524"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal" evidence="15">
    <location>
      <begin position="207"/>
      <end position="209"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal" evidence="15">
    <location>
      <begin position="221"/>
      <end position="226"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="11">
    <location>
      <begin position="366"/>
      <end position="385"/>
    </location>
  </feature>
  <feature type="active site" description="For poly [ADP-ribose] polymerase activity" evidence="121 123 124">
    <location>
      <position position="988"/>
    </location>
  </feature>
  <feature type="binding site" evidence="6 33 41 42 128 129 132 133 134 135 136">
    <location>
      <position position="21"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="6 33 41 42 128 129 132 133 134 135 136">
    <location>
      <position position="24"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="6 33 41 42 128 129 132 133 134 135 136">
    <location>
      <position position="53"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="6 33 41 42 128 129 132 133 134 135 136">
    <location>
      <position position="56"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="6 33 42 130 131 132">
    <location>
      <position position="125"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="6 33 42 130 131 132">
    <location>
      <position position="128"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="6 33 42 130 131 132">
    <location>
      <position position="159"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="6 33 42 130 131 132">
    <location>
      <position position="162"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="10 23 41 127 133 134 135 136">
    <location>
      <position position="295"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>3</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="10 23 41 127 133 134 135 136">
    <location>
      <position position="298"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>3</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="10 23 41 127 133 134 135 136">
    <location>
      <position position="311"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>3</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="10 23 41 127 133 134 135 136">
    <location>
      <position position="321"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>3</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="3">
    <location>
      <begin position="862"/>
      <end position="864"/>
    </location>
    <ligand>
      <name>NAD(+)</name>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="3">
    <location>
      <position position="871"/>
    </location>
    <ligand>
      <name>NAD(+)</name>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="3">
    <location>
      <position position="878"/>
    </location>
    <ligand>
      <name>NAD(+)</name>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="3">
    <location>
      <position position="904"/>
    </location>
    <ligand>
      <name>NAD(+)</name>
      <dbReference type="ChEBI" id="CHEBI:57540"/>
    </ligand>
  </feature>
  <feature type="site" description="Cleavage; by caspase-3 and caspase-7" evidence="13 40 101">
    <location>
      <begin position="214"/>
      <end position="215"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylalanine" evidence="106 158">
    <location>
      <position position="2"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="156 159">
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="154">
    <location>
      <position position="97"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="154">
    <location>
      <position position="105"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="154">
    <location>
      <position position="131"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="159">
    <location>
      <position position="177"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="152 159">
    <location>
      <position position="179"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="159">
    <location>
      <position position="185"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="159">
    <location>
      <position position="274"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="159">
    <location>
      <position position="277"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="160">
    <location>
      <position position="364"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="153">
    <location>
      <position position="368"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl aspartic acid" evidence="28">
    <location>
      <position position="387"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="407"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="413"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="435"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="437"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="444"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="445"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="448"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="456"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="471"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="484"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="28">
    <location>
      <position position="488"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="28">
    <location>
      <position position="491"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="59 63 77 84 86">
    <location>
      <position position="499"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="63">
    <location>
      <position position="504"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="59 63 84 86">
    <location>
      <position position="507"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="513"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="514"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="59 63 84 86">
    <location>
      <position position="519"/>
    </location>
  </feature>
  <feature type="modified residue" description="PolyADP-ribosyl glutamic acid" evidence="4">
    <location>
      <position position="520"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-(ADP-ribosyl)lysine" evidence="36 58">
    <location>
      <position position="521"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by PRKDC" evidence="99">
    <location>
      <position position="594"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="154">
    <location>
      <position position="600"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="154">
    <location>
      <position position="621"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="153 155 156 157 159">
    <location>
      <position position="782"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="159">
    <location>
      <position position="786"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="165">
    <location>
      <position position="192"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="161">
    <location>
      <position position="203"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="164 165">
    <location>
      <position position="203"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="165">
    <location>
      <position position="249"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="164 165">
    <location>
      <position position="467"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="161">
    <location>
      <position position="486"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="161 162 164 165">
    <location>
      <position position="486"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="162 163 164 165">
    <location>
      <position position="512"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="165">
    <location>
      <position position="528"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="161">
    <location>
      <position position="748"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="162 165">
    <location>
      <position position="748"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_050460" description="In dbSNP:rs3738708.">
    <original>F</original>
    <variation>L</variation>
    <location>
      <position position="54"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_014714" description="In dbSNP:rs1805409." evidence="107">
    <original>A</original>
    <variation>T</variation>
    <location>
      <position position="188"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_019171" description="In dbSNP:rs3219057." evidence="107">
    <original>V</original>
    <variation>I</variation>
    <location>
      <position position="334"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_050461" description="In dbSNP:rs2230484.">
    <original>P</original>
    <variation>S</variation>
    <location>
      <position position="377"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_019172" description="In dbSNP:rs3219062." evidence="107">
    <original>S</original>
    <variation>Y</variation>
    <location>
      <position position="383"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_035852" description="In a breast cancer sample; somatic mutation." evidence="20">
    <original>E</original>
    <variation>V</variation>
    <location>
      <position position="488"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_014715" description="In dbSNP:rs1136410." evidence="16 107">
    <original>V</original>
    <variation>A</variation>
    <location>
      <position position="762"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_019173" description="In dbSNP:rs3219145." evidence="60 107">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="940"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished DNA-binding." evidence="33">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="18"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect translocation into the cytosol." evidence="99">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="25"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished DNA-binding." evidence="33">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="34"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished binding to DNA strand breaks." evidence="42">
    <original>R</original>
    <variation>E</variation>
    <location>
      <position position="34"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect DNA-binding." evidence="33">
    <original>Q</original>
    <variation>A</variation>
    <location>
      <position position="40"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect." evidence="33">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect." evidence="33">
    <original>P</original>
    <variation>G</variation>
    <location>
      <position position="42"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect." evidence="33">
    <original>M</original>
    <variation>A</variation>
    <location>
      <position position="43"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased homodimerization." evidence="42">
    <original>M</original>
    <variation>D</variation>
    <location>
      <position position="43"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished DNA-binding." evidence="33">
    <original>FDGKV</original>
    <variation>ADGKA</variation>
    <location>
      <begin position="44"/>
      <end position="48"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished DNA-binding." evidence="33">
    <original>F</original>
    <variation>A</variation>
    <location>
      <position position="44"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased homodimerization." evidence="42">
    <original>F</original>
    <variation>D</variation>
    <location>
      <position position="44"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect DNA-binding. Decreased poly-ADP-ribosyltransferase activity." evidence="33 41">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="45"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished prolonged residence (trapping) to chromatin." evidence="93">
    <location>
      <begin position="119"/>
      <end position="120"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased DNA-binding." evidence="33">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="122"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished binding to DNA strand breaks." evidence="42">
    <original>R</original>
    <variation>E</variation>
    <location>
      <position position="138"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished DNA-binding." evidence="33">
    <original>LGMI</original>
    <variation>AGMA</variation>
    <location>
      <begin position="151"/>
      <end position="154"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished cleavage by caspase-7 (CASP7)." evidence="40">
    <original>D</original>
    <variation>N</variation>
    <location>
      <position position="214"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>Q</original>
    <variation>L</variation>
    <location>
      <position position="241"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased poly-ADP-ribosyltransferase activity upon binding to damaged DNA." evidence="41 52">
    <original>W</original>
    <variation>A</variation>
    <location>
      <position position="246"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased stability leading to impaired oly-ADP-ribosyltransferase activity." evidence="23">
    <original>C</original>
    <variation>A</variation>
    <location>
      <position position="298"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="314"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>V</original>
    <variation>A</variation>
    <location>
      <position position="315"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced poly-ADP-ribosyltransferase and ability to regulate chromatin compaction." evidence="32">
    <original>T</original>
    <variation>A</variation>
    <location>
      <position position="316"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>A</original>
    <variation>G</variation>
    <location>
      <position position="317"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced poly-ADP-ribosyltransferase activity. Able to bind damaged DNA, however, defects in the interdomain communication prevent unfolding of the PARP alpha-helical domain, blocking catalytic activation." evidence="32 41 52 53 72">
    <original>W</original>
    <variation>A</variation>
    <variation>R</variation>
    <variation>E</variation>
    <location>
      <position position="318"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>W</original>
    <variation>F</variation>
    <location>
      <position position="318"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>T</original>
    <variation>A</variation>
    <location>
      <position position="319"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>K</original>
    <variation>A</variation>
    <location>
      <position position="320"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect translocation into the cytosol." evidence="99">
    <original>T</original>
    <variation>A</variation>
    <location>
      <position position="325"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>LKV</original>
    <variation>DKD</variation>
    <location>
      <begin position="348"/>
      <end position="350"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>F</original>
    <variation>Y</variation>
    <location>
      <position position="357"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect auto-poly-ADP-ribosylation." evidence="32">
    <original>PP</original>
    <variation>GG</variation>
    <location>
      <begin position="358"/>
      <end position="359"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased ability of the BRCT domain to bind intact DNA; when associated with Q-418." evidence="92">
    <original>K</original>
    <variation>Q</variation>
    <location>
      <position position="394"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased ability of the BRCT domain to bind intact DNA." evidence="92">
    <original>KDEVK</original>
    <variation>QDEVQ</variation>
    <location>
      <begin position="405"/>
      <end position="409"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased ability of the BRCT domain to bind intact DNA." evidence="92">
    <original>KLTGTANK</original>
    <variation>QLTGTANQ</variation>
    <location>
      <begin position="418"/>
      <end position="425"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased ability of the BRCT domain to bind intact DNA; when associated with Q-394." evidence="92">
    <original>K</original>
    <variation>Q</variation>
    <location>
      <position position="418"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly decreased ability of the BRCT domain to bind intact DNA." evidence="92">
    <original>KK</original>
    <variation>QQ</variation>
    <location>
      <begin position="441"/>
      <end position="442"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced interaction with TIMELESS." evidence="51">
    <original>VEVV</original>
    <variation>GEVQ</variation>
    <location>
      <begin position="490"/>
      <end position="493"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes automodification on serine following interaction with HPF1, leading to delay dissociation from chromatin; when associated with A-507 and A-519." evidence="59 84 86">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="499"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes automodification on serine following interaction with HPF1, leading to delay dissociation from chromatin; when associated with A-499 and A-519." evidence="59 84 86">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="507"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes automodification on serine following interaction with HPF1, leading to delay dissociation from chromatin; when associated with A-499 and A-507." evidence="59 84 86">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="519"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased poly-ADP-ribosyltransferase activity upon binding to damaged DNA." evidence="41 52">
    <original>N</original>
    <variation>A</variation>
    <location>
      <position position="567"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased poly-ADP-ribosyltransferase activity upon binding to damaged DNA. Abolished ability to mediate DNA intrastrand transfer (named 'monkey-bar mechanism')." evidence="41 52">
    <original>W</original>
    <variation>A</variation>
    <location>
      <position position="589"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased poly-ADP-ribosyltransferase activity upon binding to damaged DNA." evidence="41 52">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="591"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished phosphorylation by PRKDC, inhibiting translocation into the cytosol." evidence="99">
    <original>T</original>
    <variation>A</variation>
    <location>
      <position position="594"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased poly-ADP-ribosyltransferase activity upon binding to damaged DNA." evidence="41 52">
    <original>K</original>
    <variation>A</variation>
    <location>
      <position position="633"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased auto-poly-ADP-ribosylation." evidence="41">
    <original>LGKL</original>
    <variation>AGKA</variation>
    <location>
      <begin position="698"/>
      <end position="701"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased auto-poly-ADP-ribosylation." evidence="41">
    <original>L</original>
    <variation>A</variation>
    <location>
      <position position="713"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Leads to constitutive activity in absence of DNA damage due to unfolding of the PARP alpha-helical domain, relieving autoinhibition." evidence="41 53">
    <original>L</original>
    <variation>F</variation>
    <location>
      <position position="713"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Able to bind BAD inhibitor in absence of DNA." evidence="62">
    <original>EMLDNLLD</original>
    <variation>AMLANLLA</variation>
    <location>
      <begin position="763"/>
      <end position="770"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased auto-poly-ADP-ribosylation." evidence="41">
    <original>L</original>
    <variation>A</variation>
    <location>
      <position position="765"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Able to bind EB-47 or BAD inhibitors in absence of DNA. Released from DNA strand break independently of EB-47 or BAD inhibitors." evidence="62 72">
    <original>DNLLD</original>
    <variation>ANLLA</variation>
    <location>
      <begin position="766"/>
      <end position="770"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased auto-poly-ADP-ribosylation." evidence="41">
    <original>L</original>
    <variation>A</variation>
    <location>
      <position position="768"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased DNA-independent poly-ADP-ribosyltransferase activity." evidence="53">
    <original>A</original>
    <variation>S</variation>
    <variation>L</variation>
    <location>
      <position position="774"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="1.5% of wild-type activity." evidence="103">
    <original>L</original>
    <variation>P</variation>
    <location>
      <position position="797"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced serine ADP-ribosylation, caused by abolished interaction with HPF1." evidence="71">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="826"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased polymerase activity, leading to the production of short poly-ADP-ribose chains." evidence="89">
    <original>H</original>
    <variation>E</variation>
    <location>
      <position position="826"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with TIMELESS." evidence="51">
    <location>
      <begin position="850"/>
      <end position="851"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Poly-ADP-ribosyltransferase activity is impaired while mono-ADP-ribosyltransferase activity is not affected; produces a mixture of short and mono ADP-ribose chains." evidence="102">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="862"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased affinity for DNA damage sites." evidence="89">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="865"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="4% of wild-type activity." evidence="103">
    <original>N</original>
    <variation>S</variation>
    <location>
      <position position="868"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased DNA-independent poly-ADP-ribosyltransferase activity." evidence="53">
    <original>A</original>
    <variation>S</variation>
    <variation>L</variation>
    <location>
      <position position="870"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Increased DNA-independent poly-ADP-ribosyltransferase activity." evidence="53">
    <original>G</original>
    <variation>L</variation>
    <location>
      <position position="871"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect DNA-independent poly-ADP-ribosyltransferase activity." evidence="53">
    <original>G</original>
    <variation>S</variation>
    <location>
      <position position="871"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect DNA-independent poly-ADP-ribosyltransferase activity." evidence="53">
    <original>P</original>
    <variation>G</variation>
    <location>
      <position position="882"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect DNA-independent poly-ADP-ribosyltransferase activity." evidence="53">
    <original>EAPVT</original>
    <variation>ASSVA</variation>
    <location>
      <begin position="883"/>
      <end position="887"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect ADP-ribosyltransferase activity." evidence="102">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="883"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect DNA-independent poly-ADP-ribosyltransferase activity." evidence="53">
    <original>P</original>
    <variation>G</variation>
    <variation>S</variation>
    <location>
      <position position="885"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="&lt;0.5% of wild-type activity." evidence="103">
    <original>M</original>
    <variation>V</variation>
    <location>
      <position position="890"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes enzymatic activity." evidence="103">
    <original>K</original>
    <variation>I</variation>
    <location>
      <position position="893"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="10% of wild-type activity." evidence="103">
    <original>F</original>
    <variation>S</variation>
    <location>
      <position position="897"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="0.6% of wild-type activity." evidence="103">
    <original>D</original>
    <variation>N</variation>
    <location>
      <position position="899"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="&lt;0.5% of wild-type activity." evidence="103">
    <original>C</original>
    <variation>R</variation>
    <location>
      <position position="908"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect ADP-ribosyltransferase activity." evidence="102">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="923"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="1.5% of wild-type activity." evidence="103">
    <original>L</original>
    <variation>F</variation>
    <location>
      <position position="926"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect ADP-ribosyltransferase activity." evidence="102">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="931"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="14% of wild-type activity and increased branching 15-fold." evidence="103">
    <original>Y</original>
    <variation>H</variation>
    <location>
      <position position="986"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Poly-ADP-ribosyltransferase activity is inhibited while mono-ADP-ribosyltransferase activity is not affected; only monomers are added. Disrupts interaction with CHD1L and ability to recruit PARP2 to DNA damage sites." evidence="61 64 71 102 103">
    <original>E</original>
    <variation>A</variation>
    <variation>D</variation>
    <variation>Q</variation>
    <variation>K</variation>
    <location>
      <position position="988"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with TIMELESS." evidence="51">
    <original>D</original>
    <variation>G</variation>
    <location>
      <position position="993"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="1.5% of wild-type activity." evidence="103">
    <original>L</original>
    <variation>P</variation>
    <location>
      <position position="1003"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced serine ADP-ribosylation, caused by abolished interaction with HPF1." evidence="71">
    <original>LW</original>
    <variation>EE</variation>
    <location>
      <begin position="1013"/>
      <end position="1014"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; AAB59447." evidence="118" ref="2">
    <original>G</original>
    <variation>E</variation>
    <location>
      <position position="17"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAA60137." evidence="118" ref="1">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="70"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; AAB59447." evidence="118" ref="2">
    <original>E</original>
    <variation>K</variation>
    <location>
      <position position="212"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; AAA60155." evidence="118" ref="3">
    <original>H</original>
    <variation>Q</variation>
    <location>
      <position position="613"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; AAA60155." evidence="118" ref="3">
    <original>N</original>
    <variation>S</variation>
    <location>
      <position position="827"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; AAA60155." evidence="118" ref="3">
    <original>C</original>
    <variation>Y</variation>
    <location>
      <position position="908"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; AAA60155." evidence="118" ref="3">
    <original>N</original>
    <variation>I</variation>
    <location>
      <position position="980"/>
    </location>
  </feature>
  <feature type="turn" evidence="169">
    <location>
      <begin position="2"/>
      <end position="5"/>
    </location>
  </feature>
  <feature type="strand" evidence="175">
    <location>
      <begin position="8"/>
      <end position="13"/>
    </location>
  </feature>
  <feature type="strand" evidence="175">
    <location>
      <begin position="15"/>
      <end position="17"/>
    </location>
  </feature>
  <feature type="turn" evidence="175">
    <location>
      <begin position="22"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="strand" evidence="169">
    <location>
      <begin position="25"/>
      <end position="27"/>
    </location>
  </feature>
  <feature type="strand" evidence="175">
    <location>
      <begin position="32"/>
      <end position="40"/>
    </location>
  </feature>
  <feature type="strand" evidence="175">
    <location>
      <begin position="42"/>
      <end position="53"/>
    </location>
  </feature>
  <feature type="helix" evidence="175">
    <location>
      <begin position="54"/>
      <end position="59"/>
    </location>
  </feature>
  <feature type="helix" evidence="175">
    <location>
      <begin position="67"/>
      <end position="70"/>
    </location>
  </feature>
  <feature type="helix" evidence="175">
    <location>
      <begin position="74"/>
      <end position="76"/>
    </location>
  </feature>
  <feature type="helix" evidence="175">
    <location>
      <begin position="79"/>
      <end position="90"/>
    </location>
  </feature>
  <feature type="strand" evidence="171">
    <location>
      <begin position="102"/>
      <end position="105"/>
    </location>
  </feature>
  <feature type="strand" evidence="176">
    <location>
      <begin position="113"/>
      <end position="117"/>
    </location>
  </feature>
  <feature type="strand" evidence="176">
    <location>
      <begin position="119"/>
      <end position="121"/>
    </location>
  </feature>
  <feature type="turn" evidence="176">
    <location>
      <begin position="126"/>
      <end position="128"/>
    </location>
  </feature>
  <feature type="strand" evidence="176">
    <location>
      <begin position="137"/>
      <end position="145"/>
    </location>
  </feature>
  <feature type="strand" evidence="176">
    <location>
      <begin position="148"/>
      <end position="158"/>
    </location>
  </feature>
  <feature type="helix" evidence="176">
    <location>
      <begin position="160"/>
      <end position="165"/>
    </location>
  </feature>
  <feature type="helix" evidence="176">
    <location>
      <begin position="167"/>
      <end position="170"/>
    </location>
  </feature>
  <feature type="turn" evidence="176">
    <location>
      <begin position="174"/>
      <end position="176"/>
    </location>
  </feature>
  <feature type="helix" evidence="176">
    <location>
      <begin position="177"/>
      <end position="180"/>
    </location>
  </feature>
  <feature type="helix" evidence="176">
    <location>
      <begin position="184"/>
      <end position="186"/>
    </location>
  </feature>
  <feature type="helix" evidence="176">
    <location>
      <begin position="189"/>
      <end position="198"/>
    </location>
  </feature>
  <feature type="turn" evidence="170">
    <location>
      <begin position="204"/>
      <end position="206"/>
    </location>
  </feature>
  <feature type="strand" evidence="171">
    <location>
      <begin position="209"/>
      <end position="211"/>
    </location>
  </feature>
  <feature type="helix" evidence="173">
    <location>
      <begin position="226"/>
      <end position="255"/>
    </location>
  </feature>
  <feature type="helix" evidence="173">
    <location>
      <begin position="258"/>
      <end position="267"/>
    </location>
  </feature>
  <feature type="turn" evidence="168">
    <location>
      <begin position="273"/>
      <end position="275"/>
    </location>
  </feature>
  <feature type="helix" evidence="173">
    <location>
      <begin position="276"/>
      <end position="289"/>
    </location>
  </feature>
  <feature type="turn" evidence="173">
    <location>
      <begin position="296"/>
      <end position="298"/>
    </location>
  </feature>
  <feature type="strand" evidence="173">
    <location>
      <begin position="302"/>
      <end position="305"/>
    </location>
  </feature>
  <feature type="strand" evidence="173">
    <location>
      <begin position="308"/>
      <end position="311"/>
    </location>
  </feature>
  <feature type="strand" evidence="173">
    <location>
      <begin position="314"/>
      <end position="316"/>
    </location>
  </feature>
  <feature type="strand" evidence="173">
    <location>
      <begin position="324"/>
      <end position="327"/>
    </location>
  </feature>
  <feature type="helix" evidence="173">
    <location>
      <begin position="337"/>
      <end position="340"/>
    </location>
  </feature>
  <feature type="helix" evidence="173">
    <location>
      <begin position="342"/>
      <end position="347"/>
    </location>
  </feature>
  <feature type="turn" evidence="185">
    <location>
      <begin position="389"/>
      <end position="392"/>
    </location>
  </feature>
  <feature type="strand" evidence="185">
    <location>
      <begin position="394"/>
      <end position="397"/>
    </location>
  </feature>
  <feature type="helix" evidence="185">
    <location>
      <begin position="405"/>
      <end position="414"/>
    </location>
  </feature>
  <feature type="strand" evidence="185">
    <location>
      <begin position="418"/>
      <end position="420"/>
    </location>
  </feature>
  <feature type="strand" evidence="185">
    <location>
      <begin position="427"/>
      <end position="431"/>
    </location>
  </feature>
  <feature type="helix" evidence="185">
    <location>
      <begin position="434"/>
      <end position="438"/>
    </location>
  </feature>
  <feature type="helix" evidence="185">
    <location>
      <begin position="441"/>
      <end position="448"/>
    </location>
  </feature>
  <feature type="strand" evidence="185">
    <location>
      <begin position="452"/>
      <end position="455"/>
    </location>
  </feature>
  <feature type="helix" evidence="185">
    <location>
      <begin position="458"/>
      <end position="464"/>
    </location>
  </feature>
  <feature type="helix" evidence="185">
    <location>
      <begin position="469"/>
      <end position="472"/>
    </location>
  </feature>
  <feature type="turn" evidence="185">
    <location>
      <begin position="473"/>
      <end position="475"/>
    </location>
  </feature>
  <feature type="helix" evidence="184">
    <location>
      <begin position="535"/>
      <end position="537"/>
    </location>
  </feature>
  <feature type="turn" evidence="184">
    <location>
      <begin position="540"/>
      <end position="542"/>
    </location>
  </feature>
  <feature type="strand" evidence="184">
    <location>
      <begin position="543"/>
      <end position="545"/>
    </location>
  </feature>
  <feature type="strand" evidence="183">
    <location>
      <begin position="548"/>
      <end position="550"/>
    </location>
  </feature>
  <feature type="strand" evidence="184">
    <location>
      <begin position="554"/>
      <end position="561"/>
    </location>
  </feature>
  <feature type="turn" evidence="184">
    <location>
      <begin position="562"/>
      <end position="565"/>
    </location>
  </feature>
  <feature type="strand" evidence="184">
    <location>
      <begin position="566"/>
      <end position="581"/>
    </location>
  </feature>
  <feature type="strand" evidence="184">
    <location>
      <begin position="583"/>
      <end position="591"/>
    </location>
  </feature>
  <feature type="strand" evidence="184">
    <location>
      <begin position="597"/>
      <end position="606"/>
    </location>
  </feature>
  <feature type="helix" evidence="184">
    <location>
      <begin position="607"/>
      <end position="622"/>
    </location>
  </feature>
  <feature type="strand" evidence="184">
    <location>
      <begin position="639"/>
      <end position="641"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="667"/>
      <end position="676"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="679"/>
      <end position="688"/>
    </location>
  </feature>
  <feature type="turn" evidence="180">
    <location>
      <begin position="693"/>
      <end position="695"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="698"/>
      <end position="700"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="703"/>
      <end position="721"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="726"/>
      <end position="739"/>
    </location>
  </feature>
  <feature type="strand" evidence="182">
    <location>
      <begin position="745"/>
      <end position="747"/>
    </location>
  </feature>
  <feature type="strand" evidence="166">
    <location>
      <begin position="752"/>
      <end position="754"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="755"/>
      <end position="779"/>
    </location>
  </feature>
  <feature type="strand" evidence="177">
    <location>
      <begin position="785"/>
      <end position="787"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="790"/>
      <end position="796"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="799"/>
      <end position="803"/>
    </location>
  </feature>
  <feature type="strand" evidence="172">
    <location>
      <begin position="806"/>
      <end position="808"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="809"/>
      <end position="820"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="824"/>
      <end position="826"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="829"/>
      <end position="841"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="844"/>
      <end position="848"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="849"/>
      <end position="851"/>
    </location>
  </feature>
  <feature type="strand" evidence="174">
    <location>
      <begin position="853"/>
      <end position="855"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="857"/>
      <end position="863"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="866"/>
      <end position="868"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="869"/>
      <end position="875"/>
    </location>
  </feature>
  <feature type="strand" evidence="186">
    <location>
      <begin position="882"/>
      <end position="884"/>
    </location>
  </feature>
  <feature type="helix" evidence="180">
    <location>
      <begin position="886"/>
      <end position="888"/>
    </location>
  </feature>
  <feature type="strand" evidence="167">
    <location>
      <begin position="889"/>
      <end position="891"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="893"/>
      <end position="900"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="901"/>
      <end position="905"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="906"/>
      <end position="908"/>
    </location>
  </feature>
  <feature type="strand" evidence="181">
    <location>
      <begin position="912"/>
      <end position="914"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="916"/>
      <end position="925"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="928"/>
      <end position="934"/>
    </location>
  </feature>
  <feature type="strand" evidence="179">
    <location>
      <begin position="938"/>
      <end position="940"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="947"/>
      <end position="950"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="952"/>
      <end position="956"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="958"/>
      <end position="960"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="962"/>
      <end position="964"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="967"/>
      <end position="969"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="974"/>
      <end position="976"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="983"/>
      <end position="986"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="988"/>
      <end position="993"/>
    </location>
  </feature>
  <feature type="helix" evidence="178">
    <location>
      <begin position="994"/>
      <end position="996"/>
    </location>
  </feature>
  <feature type="strand" evidence="178">
    <location>
      <begin position="997"/>
      <end position="1009"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="P11103"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="2">
    <source>
      <dbReference type="UniProtKB" id="P27008"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="3">
    <source>
      <dbReference type="UniProtKB" id="Q9UGN5"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="4"/>
  <evidence type="ECO:0000255" key="5">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00033"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="6">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00264"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="7">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00397"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="8">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00398"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="9">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU01321"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="10">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU01351"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="11">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="10467406"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="10497198"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="15044383"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="1505517"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="15607977"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="16374543"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="16904257"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="16959974"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="17177976"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="17396150"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="18055453"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="18172500"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="19344625"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="19661379"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="19710015"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="19764761"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="19779455"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="30">
    <source>
      <dbReference type="PubMed" id="20064938"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="31">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="32">
    <source>
      <dbReference type="PubMed" id="20388712"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="33">
    <source>
      <dbReference type="PubMed" id="21233213"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="34">
    <source>
      <dbReference type="PubMed" id="21266351"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="35">
    <source>
      <dbReference type="PubMed" id="21577210"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="36">
    <source>
      <dbReference type="PubMed" id="21680843"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="37">
    <source>
      <dbReference type="PubMed" id="21799911"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="38">
    <source>
      <dbReference type="PubMed" id="22300411"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="39">
    <source>
      <dbReference type="PubMed" id="22451931"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="40">
    <source>
      <dbReference type="PubMed" id="22464733"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="41">
    <source>
      <dbReference type="PubMed" id="22582261"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="42">
    <source>
      <dbReference type="PubMed" id="22683995"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="43">
    <source>
      <dbReference type="PubMed" id="22753495"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="44">
    <source>
      <dbReference type="PubMed" id="22863007"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="45">
    <source>
      <dbReference type="PubMed" id="23213405"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="46">
    <source>
      <dbReference type="PubMed" id="23230272"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="47">
    <source>
      <dbReference type="PubMed" id="23966166"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="48">
    <source>
      <dbReference type="PubMed" id="24906880"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="49">
    <source>
      <dbReference type="PubMed" id="25043379"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="50">
    <source>
      <dbReference type="PubMed" id="25533949"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="51">
    <source>
      <dbReference type="PubMed" id="26344098"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="52">
    <source>
      <dbReference type="PubMed" id="26626479"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="53">
    <source>
      <dbReference type="PubMed" id="26626480"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="54">
    <source>
      <dbReference type="PubMed" id="27067600"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="55">
    <source>
      <dbReference type="PubMed" id="27256882"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="56">
    <source>
      <dbReference type="PubMed" id="27257257"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="57">
    <source>
      <dbReference type="PubMed" id="27471034"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="58">
    <source>
      <dbReference type="PubMed" id="27568560"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="59">
    <source>
      <dbReference type="PubMed" id="28190768"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="60">
    <source>
      <dbReference type="PubMed" id="2891139"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="61">
    <source>
      <dbReference type="PubMed" id="29220653"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="62">
    <source>
      <dbReference type="PubMed" id="29487285"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="63">
    <source>
      <dbReference type="PubMed" id="29954836"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="64">
    <source>
      <dbReference type="PubMed" id="30104678"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="65">
    <source>
      <dbReference type="PubMed" id="30257210"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="66">
    <source>
      <dbReference type="PubMed" id="30356214"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="67">
    <source>
      <dbReference type="PubMed" id="30675909"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="68">
    <source>
      <dbReference type="PubMed" id="31609975"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="69">
    <source>
      <dbReference type="PubMed" id="31796734"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="70">
    <source>
      <dbReference type="PubMed" id="31848352"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="71">
    <source>
      <dbReference type="PubMed" id="32028527"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="72">
    <source>
      <dbReference type="PubMed" id="32241924"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="73">
    <source>
      <dbReference type="PubMed" id="32315358"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="74">
    <source>
      <dbReference type="PubMed" id="32358582"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="75">
    <source>
      <dbReference type="PubMed" id="32844745"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="76">
    <source>
      <dbReference type="PubMed" id="33168626"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="77">
    <source>
      <dbReference type="PubMed" id="33186521"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="78">
    <source>
      <dbReference type="PubMed" id="33361107"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="79">
    <source>
      <dbReference type="PubMed" id="33412112"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="80">
    <source>
      <dbReference type="PubMed" id="33589610"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="81">
    <source>
      <dbReference type="PubMed" id="33683197"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="82">
    <source>
      <dbReference type="PubMed" id="34049076"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="83">
    <source>
      <dbReference type="PubMed" id="34102106"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="84">
    <source>
      <dbReference type="PubMed" id="34210965"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="85">
    <source>
      <dbReference type="PubMed" id="34465625"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="86">
    <source>
      <dbReference type="PubMed" id="34625544"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="87">
    <source>
      <dbReference type="PubMed" id="34732825"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="88">
    <source>
      <dbReference type="PubMed" id="34737271"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="89">
    <source>
      <dbReference type="PubMed" id="34795260"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="90">
    <source>
      <dbReference type="PubMed" id="34811483"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="91">
    <source>
      <dbReference type="PubMed" id="34874266"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="92">
    <source>
      <dbReference type="PubMed" id="34919819"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="93">
    <source>
      <dbReference type="PubMed" id="35013556"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="94">
    <source>
      <dbReference type="PubMed" id="35025765"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="95">
    <source>
      <dbReference type="PubMed" id="35104452"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="96">
    <source>
      <dbReference type="PubMed" id="35124853"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="97">
    <source>
      <dbReference type="PubMed" id="35219381"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="98">
    <source>
      <dbReference type="PubMed" id="35393539"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="99">
    <source>
      <dbReference type="PubMed" id="35460603"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="100">
    <source>
      <dbReference type="PubMed" id="37823600"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="101">
    <source>
      <dbReference type="PubMed" id="7596430"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="102">
    <source>
      <dbReference type="PubMed" id="7852410"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="103">
    <source>
      <dbReference type="PubMed" id="9315851"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="104">
    <source>
      <dbReference type="PubMed" id="9518481"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="105">
    <source>
      <dbReference type="PubMed" id="9721847"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="106">
    <source ref="12"/>
  </evidence>
  <evidence type="ECO:0000269" key="107">
    <source ref="5"/>
  </evidence>
  <evidence type="ECO:0000303" key="108">
    <source>
      <dbReference type="PubMed" id="15607977"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="109">
    <source>
      <dbReference type="PubMed" id="19764761"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="110">
    <source>
      <dbReference type="PubMed" id="21680843"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="111">
    <source>
      <dbReference type="PubMed" id="2824474"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="112">
    <source>
      <dbReference type="PubMed" id="29954836"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="113">
    <source>
      <dbReference type="PubMed" id="3120710"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="114">
    <source>
      <dbReference type="PubMed" id="33168626"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="115">
    <source>
      <dbReference type="PubMed" id="35104452"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="116">
    <source>
      <dbReference type="PubMed" id="9721847"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="117">
    <source ref="11"/>
  </evidence>
  <evidence type="ECO:0000305" key="118"/>
  <evidence type="ECO:0000305" key="119">
    <source>
      <dbReference type="PubMed" id="29954836"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="120">
    <source>
      <dbReference type="PubMed" id="30257210"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="121">
    <source>
      <dbReference type="PubMed" id="32028527"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="122">
    <source>
      <dbReference type="PubMed" id="7596430"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="123">
    <source>
      <dbReference type="PubMed" id="7852410"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="124">
    <source>
      <dbReference type="PubMed" id="9315851"/>
    </source>
  </evidence>
  <evidence type="ECO:0000312" key="125">
    <source>
      <dbReference type="HGNC" id="HGNC:270"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="126">
    <source>
      <dbReference type="PDB" id="2N8A"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="127">
    <source>
      <dbReference type="PDB" id="2RIQ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="128">
    <source>
      <dbReference type="PDB" id="3OD8"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="129">
    <source>
      <dbReference type="PDB" id="3ODA"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="130">
    <source>
      <dbReference type="PDB" id="3ODC"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="131">
    <source>
      <dbReference type="PDB" id="3ODE"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="132">
    <source>
      <dbReference type="PDB" id="4AV1"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="133">
    <source>
      <dbReference type="PDB" id="4DQY"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="134">
    <source>
      <dbReference type="PDB" id="4OPX"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="135">
    <source>
      <dbReference type="PDB" id="4OQA"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="136">
    <source>
      <dbReference type="PDB" id="4OQB"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="137">
    <source>
      <dbReference type="PDB" id="4XHU"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="138">
    <source>
      <dbReference type="PDB" id="5DS3"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="139">
    <source>
      <dbReference type="PDB" id="6BHV"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="140">
    <source>
      <dbReference type="PDB" id="6M3I"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="141">
    <source>
      <dbReference type="PDB" id="6NTU"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="142">
    <source>
      <dbReference type="PDB" id="6VKK"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="143">
    <source>
      <dbReference type="PDB" id="6VKO"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="144">
    <source>
      <dbReference type="PDB" id="6VKQ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="145">
    <source>
      <dbReference type="PDB" id="7KK2"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="146">
    <source>
      <dbReference type="PDB" id="7KK3"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="147">
    <source>
      <dbReference type="PDB" id="7KK4"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="148">
    <source>
      <dbReference type="PDB" id="7KK5"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="149">
    <source>
      <dbReference type="PDB" id="7KK6"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="150">
    <source>
      <dbReference type="PDB" id="7SCY"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="151">
    <source>
      <dbReference type="PDB" id="7SCZ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="152">
    <source>
      <dbReference type="PubMed" id="17525332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="153">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="154">
    <source>
      <dbReference type="PubMed" id="19608861"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="155">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="156">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="157">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="158">
    <source>
      <dbReference type="PubMed" id="22814378"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="159">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="160">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="161">
    <source>
      <dbReference type="PubMed" id="25114211"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="162">
    <source>
      <dbReference type="PubMed" id="25218447"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="163">
    <source>
      <dbReference type="PubMed" id="25755297"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="164">
    <source>
      <dbReference type="PubMed" id="25772364"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="165">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="166">
    <source>
      <dbReference type="PDB" id="1UK0"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="167">
    <source>
      <dbReference type="PDB" id="1WOK"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="168">
    <source>
      <dbReference type="PDB" id="2JVN"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="169">
    <source>
      <dbReference type="PDB" id="2L30"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="170">
    <source>
      <dbReference type="PDB" id="2L31"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="171">
    <source>
      <dbReference type="PDB" id="2N8A"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="172">
    <source>
      <dbReference type="PDB" id="2RCW"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="173">
    <source>
      <dbReference type="PDB" id="2RIQ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="174">
    <source>
      <dbReference type="PDB" id="3GN7"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="175">
    <source>
      <dbReference type="PDB" id="3OD8"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="176">
    <source>
      <dbReference type="PDB" id="3ODC"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="177">
    <source>
      <dbReference type="PDB" id="4R6E"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="178">
    <source>
      <dbReference type="PDB" id="6NRH"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="179">
    <source>
      <dbReference type="PDB" id="6VKK"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="180">
    <source>
      <dbReference type="PDB" id="7AAC"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="181">
    <source>
      <dbReference type="PDB" id="7KK5"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="182">
    <source>
      <dbReference type="PDB" id="7ONS"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="183">
    <source>
      <dbReference type="PDB" id="7S68"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="184">
    <source>
      <dbReference type="PDB" id="7S6H"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="185">
    <source>
      <dbReference type="PDB" id="7SCZ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="186">
    <source>
      <dbReference type="PDB" id="8FZ1"/>
    </source>
  </evidence>
  <sequence length="1014" mass="113084" checksum="6A5FC01EB91C046B" modified="2007-01-23" version="4">MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKGQDGIGSKAEKTLGDFAAEYAKSNRSTCKGCMEKIEKGQVRLSKKMVDPEKPQLGMIDRWYHPGCFVKNREELGFRPEYSASQLKGFSLLATEDKEALKKQLPGVKSEGKRKGDEVDGVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVAATPPPSTASAPAAVNSSASADKPLSNMKILTLGKLSRNKDEVKAMIEKLGGKLTGTANKASLCISTKKEVEKMNKKMEEVKEANIRVVSEDFLQDVSASTKSLQELFLAHILSPWGAEVKAEPVEVVAPRGKSGAALSKKSKGQVKEEGINKSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLW</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>